I 

114TH CONGRESS 

1ST SESSION H. R. 953 

To authorize the Attorney General to award grants to address the national 

epidemics of prescription opioid abuse and heroin use. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 12, 2015 

Mr. SENSENBRENNER (for himself, Mr. RYAN of Ohio, Ms. DUCKWORTH, Mr. 

CHABOT, Mr. MARINO, Mr. SCOTT of Virginia, and Mr. JOYCE) introduced the following bill; which was referred to the Committee on the Judiciary, and in addition to the Committees on Energy and Commerce and 

Education and the Workforce, for a period to be subsequently determined 

by the Speaker, in each case for consideration of such provisions as fall 

within the jurisdiction of the committee concerned 

A BILL 

To authorize the Attorney General to award grants to address the national epidemics of prescription opioid abuse 

and heroin use. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE; TABLE OF CONTENTS. 

4 (a) SHORT TITLE.—This Act may be cited as the 

5 ‘‘Comprehensive Addiction and Recovery Act of 2015’’. 

6 (b) TABLE OF CONTENTS.—The table of contents for 

7 this Act is as follows: 


emcdonald on DSK67QTVN1PROD with BILLS
2 

•HR 953 IH

Sec. 1. Short title; table of contents. 

Sec. 2. Findings. 

Sec. 3. Definitions. 

TITLE I—PREVENTION AND EDUCATION 

Sec. 101. Development of best prescribing practices. 

Sec. 102. National education campaign. 

Sec. 103. Community-based coalition enhancement grants to address local drug 

crises. 

TITLE II—LAW ENFORCEMENT AND TREATMENT 

Sec. 201. Treatment alternative to incarceration programs. 

Sec. 202. Law enforcement naloxone training and implementation demonstration. 

Sec. 203. Prescription drug take back expansion. 

TITLE III—TREATMENT AND RECOVERY 

Sec. 301. Evidence-based opioid and heroin treatment and interventions demonstration. 

Sec. 302. Criminal justice medication assisted treatment and interventions demonstration. 

Sec. 303. National youth recovery initiative. 

Sec. 304. Building communities of recovery. 

TITLE IV—ADDRESSING COLLATERAL CONSEQUENCES 

Sec. 401. Correctional education demonstration grant program. 

Sec. 402. Revision of FAFSA form. 

Sec. 403. National Task Force on Recovery and Collateral Consequences. 

TITLE V—ADDICTION AND TREATMENT SERVICES FOR WOMEN, 

FAMILIES, AND VETERANS 

Sec. 501. Authority to award competitive grants to address opioid and heroin 

abuse by pregnant and parenting female offenders. 

Sec. 502. Grants for family-based substance abuse treatment. 

Sec. 503. Veterans’ treatment courts. 

TITLE VI—INCENTIVIZING STATE COMPREHENSIVE INITIATIVES 

TO ADDRESS OPIOID AND HEROIN ABUSE 

Sec. 601. State demonstration grants for comprehensive opioid abuse response. 

TITLE VII—OFFSET; GAO REPORT 

Sec. 701. Offset. 

Sec. 702. GAO report on IMD exclusion. 

1 SEC. 2. FINDINGS. 

2 Congress finds the following: 

3 (1) The abuse of heroin and prescription pain4 killers is having a devastating effect on public health 


emcdonald on DSK67QTVN1PROD with BILLS
3 

•HR 953 IH

1 and safety in communities across the United States. 

2 According to the Centers for Disease Control and 

3 Prevention, drug overdose deaths now surpass traffic 

4 crashes in the number of deaths caused by injury in 

5 the United States. In 2011, an average of about 110 

6 people in the United States died from drug overdose 

7 every day. 

8 (2) Law enforcement officials and treatment ex9 perts throughout the country report that many pre10 scription opioid users have turned to heroin as a 

11 cheaper or more easily obtained alternative to pre12 scription drugs. 

13 (3) Opioid pain relievers are the most widely 

14 misused or abused controlled prescription drugs 

15 (commonly referred to as ‘‘CPDs’’) and are involved 

16 in most CPD-related overdose incidents. According 

17 to the Drug Abuse Warning Network (commonly 

18 known as ‘‘DAWN’’), the estimated number of emer19 gency department visits involving nonmedical use of 

20 prescription opiates or opioids increased by 112 per21 cent between 2006 and 2010, from 84,671 to 

22 179,787. 

23 (4) According to a report by the National Asso24 ciation of State Alcohol and Drug Abuse Directors 

25 (commonly referred to as ‘‘NASADAD’’), 37 States 


emcdonald on DSK67QTVN1PROD with BILLS
4 

•HR 953 IH

1 reported an increase in admissions to treatment for 

2 heroin use during the past 2 years, while admissions 

3 to treatment for prescription opiates increased 500 

4 percent from 2000 to 2012. 

5 (5) Substance use disorders are a treatable dis6 ease. Discoveries in the science of addiction have led 

7 to advances in the treatment of substance use dis8 orders that help people stop abusing drugs and pre9 scription medications and resume their productive 

10 lives. 

11 (6) According to the National Survey on Drug 

12 Use and Health, approximately 22,700,000 people in 

13 the United States needed substance use disorder 

14 treatment in 2013, but only 2,500,000 people re15 ceived it. Furthermore, current treatment services 

16 are not adequate to meet demand. According to a re17 port commissioned by SAMHSA, there are approxi18 mately 32 providers for every 1,000 individuals 

19 needing substance use disorder treatment. In some 

20 States, the ratio is much lower. 

21 (7) Effective substance abuse prevention can 

22 yield major economic dividends. 

23 (8) According to the National Institute on Drug 

24 Abuse, when schools and communities properly im25 plement science-validated substance abuse prevention 


emcdonald on DSK67QTVN1PROD with BILLS
5 

•HR 953 IH

1 programs, abuse of alcohol, tobacco, and illicit drugs 

2 is reduced. Such programs help teachers, parents, 

3 and healthcare professionals shape the perceptions 

4 of youths about the risks of drug abuse. 

5 (9) Diverting individuals with substance use 

6 disorders from criminal justice systems into commu7 nity-based treatment can save billions of dollars and 

8 prevent sizeable numbers of crimes, arrests, and re9 incarcerations over the course of those individuals’ 

10 lives. 

11 (10) According to the Drug Enforcement Agen12 cy, more than 1,700 tons of expired, unwanted pre13 scription medications have been collected during the 

past 31 14 ⁄2 years, following the enactment of the Se15 cure and Responsible Drug Disposal Act of 2010 

16 (Public Law 111–273; 124 Stat. 2858). 

17 (11) Research shows that combining treatment 

18 medications with behavioral therapy is the best way 

19 to facilitate success for most patients. Treatment ap20 proaches must be tailored to address the drug abuse 

21 patterns and drug-related medical, psychiatric, and 

22 social problems of each individual. Different types of 

23 medications may be useful at different stages of 

24 treatment or recovery to help a patient stop using 

25 drugs, stay in treatment, and avoid relapse. 


emcdonald on DSK67QTVN1PROD with BILLS
6 

•HR 953 IH

1 (12) Research indicates that combating the 

2 opioid crisis, including abuse of prescription pain3 killers and, increasingly, heroin, requires a multi4 pronged approach that involves reducing drug diver5 sion, expanding delivery of existing treatments (in6 cluding medication assisted treatments), expanding 

7 access to overdose medications and interventions, 

8 and the development of new medications for pain 

9 that can augment the existing treatment arsenal. 

10 (13) Individuals with mental illness, especially 

11 severe mental illness, are at considerably higher risk 

12 for substance abuse than the general population, and 

13 the presence of a mental illness complicates recovery 

14 from substance abuse. 

15 SEC. 3. DEFINITIONS. 

16 In this Act— 

17 (1) the term ‘‘medication assisted treatment’’ 

18 means the use, for problems relating to heroin and 

19 other opioids, of medications approved by the Food 

20 and Drug Administration in combination with coun21 seling and behavioral therapies; 

22 (2) the term ‘‘ONDCP Recovery Branch’’ 

23 means the Recovery Branch of the Office of Na24 tional Drug Control Policy; 


emcdonald on DSK67QTVN1PROD with BILLS
7 

•HR 953 IH

1 (3) the term ‘‘opioid’’ means any drug having 

2 an addiction-forming or addiction-sustaining liability 

3 similar to morphine or being capable of conversion 

4 into a drug having such addiction-forming or addic5 tion-sustaining liability; and 

6 (4) the term ‘‘State’’ means any State of the 

7 United States, the District of Columbia, the Com8 monwealth of Puerto Rico, and any territory or pos9 session of the United States. 

10 TITLE I—PREVENTION AND 

11 EDUCATION 

12 SEC. 101. DEVELOPMENT OF BEST PRESCRIBING PRAC13 TICES. 

14 (a) INTER-AGENCY TASK FORCE.—Not later than 

15 120 days after the date of enactment of this Act, the Sec16 retary of Health and Human Services (referred to in this 

17 section as the ‘‘Secretary’’), in cooperation with the Sec18 retary of Veterans Affairs, the Secretary of Defense, and 

19 the Administrator of the Drug Enforcement Administra20 tion, shall convene a Pain Management Best Practices 

21 Inter-Agency Task Force (referred to in this section as 

22 the ‘‘task force’’). 

23 (b) MEMBERSHIP.—The task force shall be com24 prised of— 

25 (1) representatives of— 


emcdonald on DSK67QTVN1PROD with BILLS
8 

•HR 953 IH

1 (A) the Department of Health and Human 

2 Services; 

3 (B) the Department of Veterans Affairs; 

4 (C) the Department of Defense; 

5 (D) the Drug Enforcement Administration; 

6 (E) the Centers for Disease Control and 

7 Prevention; 

8 (F) the Institute of Medicine; and 

9 (G) the Office of National Drug Control 

10 Policy; 

11 (2) the Director of the National Institutes of 

12 Health; 

13 (3) physicians, dentists, and non-physician pre14 scribers; 

15 (4) pharmacists; 

16 (5) experts in the fields of pain research and 

17 addiction research; 

18 (6) representatives of— 

19 (A) pain management professional organi20 zations; 

21 (B) the mental health treatment commu22 nity; 

23 (C) the addiction treatment community; 

24 (D) pain advocacy groups; and 


emcdonald on DSK67QTVN1PROD with BILLS
9 

•HR 953 IH

1 (E) groups with expertise around overdose 

2 reversal; and 

3 (7) other stakeholders, as the Secretary deter4 mines appropriate. 

5 (c) DUTIES.—The task force shall— 

6 (1) not later than 180 days after the date on 

7 which the task force is convened under subsection 

8 (a), develop best practices for pain management (in9 cluding chronic and acute pain) and prescribing pain 

10 medication, taking into consideration— 

11 (A) existing pain management research; 

12 (B) recommendations from relevant con13 ferences; 

14 (C) ongoing efforts at the State and local 

15 levels and by medical professional organizations 

16 to develop improved pain management strate17 gies; and 

18 (D) the management of high-risk popu19 lations, other than populations who suffer pain, 

20 who— 

21 (i) may use or be prescribed 

22 benzodiazepines, alcohol, and diverted 

23 opioids; or 

24 (ii) receive opioids in the course of 

25 medical care; 


emcdonald on DSK67QTVN1PROD with BILLS
10 

•HR 953 IH

1 (2) solicit and take into consideration public 

2 comment on the practices developed under para3 graph (1), amending such best practices if appro4 priate; and 

5 (3) develop a strategy for disseminating infor6 mation about the best practices developed under 

7 paragraphs (1) and (2) to prescribers, health profes8 sionals, pharmacists, State medical boards, and 

9 other parties, as the Secretary determines appro10 priate. 

11 (d) LIMITATION.—The task force shall not have rule12 making authority. 

13 (e) REPORT.—Not later than 270 days after the date 

14 on which the task force is convened under subsection (a), 

15 the task force shall submit to Congress a report that in16 cludes— 

17 (1) the strategy for disseminating best practices 

18 developed under subsection (c); 

19 (2) the results of a feasibility study on linking 

20 best practices developed under subsection (c) to re21 ceiving and renewing registrations under section 

22 303(f) of the Controlled Substances Act (21 U.S.C. 

23 823(f)); and 

24 (3) recommendations on how to apply best 

25 practices developed under subsection (c) to improve 


emcdonald on DSK67QTVN1PROD with BILLS
11 

•HR 953 IH

1 prescribing practices at medical facilities, including 

2 medical facilities of the Veterans Health Administra3 tion. 

4 SEC. 102. NATIONAL EDUCATION CAMPAIGN. 

5 Title I of the Omnibus Crime Control and Safe 

6 Streets Act of 1968 (42 U.S.C. 3711 et seq.) is amended 

7 by adding at the end the following: 

8 ‘‘PART MM—DRUG TREATMENT GRANTS 

9 ‘‘SEC. 3031. DEFINITIONS. 

10 ‘‘In this part— 

11 ‘‘(1) the term ‘civil liability protection law’ 

12 means a State law that protects from civil liability 

13 individuals who give aid on a voluntary basis in an 

14 emergency to individuals who are ill, in peril, or oth15 erwise incapacitated; 

16 ‘‘(2) the term ‘medication assisted treatment’ 

17 means the use, for problems relating to heroin and 

18 other opioids, of medications approved by the Food 

19 and Drug Administration in combination with coun20 seling and behavioral therapies; 

21 ‘‘(3) the term ‘opioid’ means any drug having 

22 an addiction-forming or addiction-sustaining liability 

23 similar to morphine or being capable of conversion 

24 into a drug having such addiction-forming or addic25 tion-sustaining liability; and 


emcdonald on DSK67QTVN1PROD with BILLS
12 

•HR 953 IH

1 ‘‘(4) the term ‘Single State Authority for Sub2 stance Abuse’ has the meaning given the term in 

3 section 201(e) of the Second Chance Act of 2007 

4 (42 U.S.C. 17521(e)). 

5 ‘‘SEC. 3032. NATIONAL EDUCATION CAMPAIGN. 

6 ‘‘(a) DEFINITIONS.—In this section— 

7 ‘‘(1) the term ‘eligible entity’ means a State, 

8 unit of local government, or nonprofit organization; 

9 and 

10 ‘‘(2) the terms ‘elementary school’ and ‘sec11 ondary school’ have the meaning given those terms 

12 in section 9101 of the Elementary and Secondary 

13 Education Act of 1965 (20 U.S.C. 7801). 

14 ‘‘(b) PROGRAM AUTHORIZED.—The Attorney Gen15 eral, in coordination with the Secretary of Health and 

16 Human Services, the Director of the Office of National 

17 Drug Control Policy, the Secretary of Education, the Ad18 ministrator of the Substance Abuse and Mental Health 

19 Services Administration, and the Director of the Centers 

20 for Disease Control and Prevention, may make grants to 

21 eligible entities to expand educational efforts to prevent 

22 abuse of opioids, heroin, and other substances of abuse, 

23 understand addiction as a chronic disease, and promote 

24 treatment and recovery, including— 


emcdonald on DSK67QTVN1PROD with BILLS
13 

•HR 953 IH

1 ‘‘(1) parent and caretaker-focused prevention 

2 efforts, including— 

3 ‘‘(A) the development of research-based 

4 community education online and social media 

5 materials with an accompanying toolkit that 

6 can be disseminated to communities to educate 

7 parents and other caretakers of teens on— 

8 ‘‘(i) how to educate teens about opioid 

9 and heroin abuse; 

10 ‘‘(ii) how to intervene if a parent 

11 thinks or knows their teen is abusing 

12 opioids or heroin; 

13 ‘‘(iii) signs of opioid or heroin over14 dose; and 

15 ‘‘(iv) the use of naloxone to prevent 

16 death from opioid or heroin overdose; 

17 ‘‘(B) the development of detailed digital 

18 and print educational materials to accompany 

19 the online and social media materials and tool20 kit described in subparagraph (A); 

21 ‘‘(C) the development and dissemination of 

22 public service announcements to— 

23 ‘‘(i) raise awareness of heroin and 

24 opioid abuse among parents and other 

25 caretakers; 


emcdonald on DSK67QTVN1PROD with BILLS
14 

•HR 953 IH

1 ‘‘(ii) motivate parents and other care2 takers to visit online educational materials 

3 on heroin and opioid abuse; and 

4 ‘‘(iii) provide information for public 

5 health agencies and nonprofit organiza6 tions that provide overdose reversal and 

7 prevention services and community refer8 rals; and 

9 ‘‘(D) the dissemination of educational ma10 terials to the media through— 

11 ‘‘(i) a town hall or panel discussion 

12 with experts; 

13 ‘‘(ii) a press release; 

14 ‘‘(iii) an online news release; 

15 ‘‘(iv) a media tour; and 

16 ‘‘(v) sharable infographics; 

17 ‘‘(2) prevention efforts focused on teenagers, 

18 young adults, and college students, including the de19 velopment of— 

20 ‘‘(A) a national digital campaign; 

21 ‘‘(B) a community education toolkit for use 

22 by community coalitions; 

23 ‘‘(C) evidence-based resources for preven24 tion and treatment professionals targeting indiVerDate Sep 11 2014 02:36 Feb 25, 2015 Jkt 049200 PO 00000 Frm 00014 Fmt 6652 Sfmt 6201 E:\BILLS\H953.IH H953

emcdonald on DSK67QTVN1PROD with BILLS
15 

•HR 953 IH

1 viduals who are between 18 and 24 years of 

2 age, including college students; and 

3 ‘‘(D) technical support centers for preven4 tion and treatment professionals, elementary 

5 and secondary school-based professionals, and 

6 college-based professionals, including recovery 

7 staff, to implement and sustain evidence-based 

8 educational and prevention programs; 

9 ‘‘(3) campaigns to inform individuals about 

10 available resources to aid in recovery from substance 

11 use disorder; 

12 ‘‘(4) encouragement of individuals in or seeking 

13 recovery from substance use disorder to enter the 

14 health care system; or 

15 ‘‘(5) adult-focused awareness efforts, including 

16 efforts focused on older adults, relating to prescrip17 tion medication disposal, opioid and heroin abuse, 

18 signs of overdose, and the use of naloxone for rever19 sal. 

20 ‘‘(c) APPLICATION.— 

21 ‘‘(1) IN GENERAL.—An eligible entity desiring a 

22 grant under this section shall submit an application 

23 to the Attorney General— 

24 ‘‘(A) that meets the criteria under para25 graph (2); and 


emcdonald on DSK67QTVN1PROD with BILLS
16 

•HR 953 IH

1 ‘‘(B) at such time, in such manner, and 

2 accompanied by such information as the Attor3 ney General may require. 

4 ‘‘(2) CRITERIA.—An eligible entity, in submit5 ting an application under paragraph (1), shall— 

6 ‘‘(A) describe the evidence-based method7 ology and outcome measurements that will be 

8 used to evaluate the program funded with a 

9 grant under this section; 

10 ‘‘(B) specifically explain how the measure11 ments described in subparagraph (A) will pro12 vide valid measures of the impact of the pro13 gram described in subparagraph (A); 

14 ‘‘(C) describe how the program described 

15 in subparagraph (A) could be broadly replicated 

16 if demonstrated to be effective; 

17 ‘‘(D) demonstrate that all planned services 

18 will be research-informed, which may include 

19 evidence-based practices documented in— 

20 ‘‘(i) the report of the Institute of 

21 Medicine entitled ‘Preventing Mental, 

22 Emotional, and Behavioral Disorders 

23 Among Young People’; or 

24 ‘‘(ii) the National Registry of Effec25 tive Programs and Practices (commonly reVerDate Sep 11 2014 02:36 Feb 25, 2015 Jkt 049200 PO 00000 Frm 00016 Fmt 6652 Sfmt 6201 E:\BILLS\H953.IH H953

emcdonald on DSK67QTVN1PROD with BILLS
17 

•HR 953 IH

1 ferred to as ‘NREPP’) of the Substance 

2 Abuse and Mental Health Administration; 

3 and 

4 ‘‘(E) demonstrate that the eligible entity 

5 will effectively integrate and sustain the pro6 gram described in subparagraph (A) into cur7 riculum or community outreach efforts. 

8 ‘‘(d) USE OF FUNDS.—A grantee shall use a grant 

9 received under this section for expenses of educational ef10 forts to— 

11 ‘‘(1) prevent abuse of opioids, heroin, alcohol, 

12 and other drugs; or 

13 ‘‘(2) promote treatment and recovery. 

14 ‘‘(e) DURATION.—The Attorney General shall award 

15 grants under this section for a period not to exceed 2 

16 years. 

17 ‘‘(f) PRIORITY CONSIDERATION WITH RESPECT TO

18 STATES.—In awarding grants to States under this sec19 tion, the Attorney General shall give priority to a State 

20 that provides civil liability protection for first responders, 

21 health professionals, and family members administering 

22 naloxone to counteract opioid overdoses by— 

23 ‘‘(1) enacting legislation that provides such civil 

24 liability protection; or 


emcdonald on DSK67QTVN1PROD with BILLS
18 

•HR 953 IH

1 ‘‘(2) providing a certification by the attorney 

2 general of the State that the attorney general has— 

3 ‘‘(A) reviewed any applicable civil liability 

4 protection law to determine the applicability of 

5 the law with respect to first responders, health 

6 care professionals, family members, and other 

7 individuals who may administer naloxone to in8 dividuals reasonably believed to be suffering 

9 from opioid overdose; and 

10 ‘‘(B) concluded that the law described in 

11 subparagraph (A) provides adequate civil liabil12 ity protection applicable to such persons. 

13 ‘‘(g) INFORMATION SHARING.—The Office of the At14 torney General, in coordination with the Substance Abuse 

15 and Mental Health Services Administration and the De16 partment of Education, shall review existing evidence17 based programs and emerging practices and programs and 

18 provide information to schools and communities about 

19 such programs and practices. 

20 ‘‘(h) AUTHORIZATION OF APPROPRIATIONS.—There 

21 are authorized to be appropriated to carry out this section 

22 $2,500,000 for each of fiscal years 2016 through 2020.’’. 


emcdonald on DSK67QTVN1PROD with BILLS
19 

•HR 953 IH

1 SEC. 103. COMMUNITY-BASED COALITION ENHANCEMENT 

2 GRANTS TO ADDRESS LOCAL DRUG CRISES. 

3 Part MM of title I of the Omnibus Crime Control 

4 and Safe Streets Act of 1968, as added by section 102, 

5 is amended by adding at the end the following: 

6 ‘‘SEC. 3033. COMMUNITY-BASED COALITION ENHANCEMENT 

7 GRANTS TO ADDRESS LOCAL DRUG CRISES. 

8 ‘‘(a) DEFINITIONS.—In this section— 

9 ‘‘(1) the term ‘Drug-Free Communities Act of 

10 1997’ means chapter 2 of the National Narcotics 

11 Leadership Act of 1988 (21 U.S.C. 1521 et seq.); 

12 ‘‘(2) the term ‘eligible entity’ means an organi13 zation that— 

14 ‘‘(A) on or before the date of submitting 

15 an application for a grant under this section, 

16 receives or has received a grant under the 

17 Drug-Free Communities Act of 1997; and 

18 ‘‘(B) has documented, using local data, 

19 rates of abuse of opioids at levels that are— 

20 ‘‘(i) significantly higher than the na21 tional average as determined by the Attor22 ney General (including appropriate consid23 eration of the Monitoring the Future Sur24 vey published by the National Institute on 

25 Drug Abuse and the National Survey on 

26 Drug Use and Health by the Substance 


emcdonald on DSK67QTVN1PROD with BILLS
20 

•HR 953 IH

1 Abuse and Mental Health Service Adminis2 tration); or 

3 ‘‘(ii) higher than the national average, 

4 as determined by the Attorney General (in5 cluding appropriate consideration of the 

6 surveys described in clause (i)), over a sus7 tained period of time; and 

8 ‘‘(3) the term ‘local drug crisis’ means, with re9 spect to the area served by an eligible entity— 

10 ‘‘(A) a sudden increase in the abuse of 

11 opioids, as documented by local data; or 

12 ‘‘(B) the abuse of prescription medications, 

13 specifically opioids, that is significantly higher 

14 than the national average, over a sustained pe15 riod of time, as documented by local data. 

16 ‘‘(b) PROGRAM AUTHORIZED.—The Attorney Gen17 eral, in coordination with the Director, may make grants 

18 to eligible entities to implement comprehensive commu19 nity-wide strategies that address local drug crises within 

20 the area served by the eligible entity. 

21 ‘‘(c) APPLICATION.— 

22 ‘‘(1) IN GENERAL.—An eligible entity desiring a 

23 grant under this section shall submit an application 

24 to the Attorney General at such time, in such manVerDate Sep 11 2014 02:36 Feb 25, 2015 Jkt 049200 PO 00000 Frm 00020 Fmt 6652 Sfmt 6201 E:\BILLS\H953.IH H953

emcdonald on DSK67QTVN1PROD with BILLS
21 

•HR 953 IH

1 ner, and accompanied by such information as the 

2 Attorney General may require. 

3 ‘‘(2) CRITERIA.—As part of an application for 

4 a grant under this section, the Attorney General 

5 shall require an eligible entity to submit a detailed, 

6 comprehensive, multi-sector plan for addressing the 

7 local drug crisis within the area served by the eligi8 ble entity. 

9 ‘‘(d) USE OF FUNDS.—An eligible entity shall use a 

10 grant received under this section— 

11 ‘‘(1) for programs designed to implement com12 prehensive community-wide prevention strategies to 

13 address local drug crisis in the area served by the 

14 eligible entity, in accordance with the plan submitted 

15 under subsection (c)(2); and 

16 ‘‘(2) to obtain specialized training and technical 

17 assistance from the organization funded under sec18 tion 4 of Public Law 107–82 (21 U.S.C. 1521 note). 

19 ‘‘(e) GRANT AMOUNTS AND DURATION.— 

20 ‘‘(1) AMOUNTS.—The Attorney General may 

21 not award a grant under this section for a fiscal 

22 year in an amount that exceeds— 

23 ‘‘(A) the amount of non-Federal funds 

24 raised by the eligible entity, including in-kind 

25 contributions, for that fiscal year; or 


emcdonald on DSK67QTVN1PROD with BILLS
22 

•HR 953 IH

1 ‘‘(B) $75,000. 

2 ‘‘(2) DURATION.—The Attorney General shall 

3 award grants under this section for a period not to 

4 exceed 4 years. 

5 ‘‘(f) SUPPLEMENT NOT SUPPLANT.—An eligible enti6 ty shall use Federal funds received under this section only 

7 to supplement the funds that would, in the absence of 

8 those Federal funds, be made available from other Federal 

9 and non-Federal sources for the activities described in this 

10 section, and not to supplant those funds. 

11 ‘‘(g) EVALUATION.—A grant under this section shall 

12 be subject to the same evaluation requirements and proce13 dures as the evaluation requirements and procedures im14 posed on the recipient of a grant under the Drug-Free 

15 Communities Act of 1997. 

16 ‘‘(h) LIMITATION ON ADMINISTRATIVE EXPENSES.— 

17 Not more than 8 percent of the amounts made available 

18 pursuant to subsection (i) for a fiscal year may be used 

19 by the Attorney General to pay for administrative ex20 penses. 

21 ‘‘(i) AUTHORIZATION OF APPROPRIATIONS.—There 

22 are authorized to be appropriated to carry out this section 

23 $5,000,000 for each of fiscal years 2016 through 2020.’’. 


emcdonald on DSK67QTVN1PROD with BILLS
23 

•HR 953 IH

1 TITLE II—LAW ENFORCEMENT 

2 AND TREATMENT 

3 SEC. 201. TREATMENT ALTERNATIVE TO INCARCERATION 

4 PROGRAMS. 

5 Part MM of the Omnibus Crime Control and Safe 

6 Streets Act of 1968, as amended by section 103, is amend7 ed by adding at the end the following: 

8 ‘‘SEC. 3034. TREATMENT ALTERNATIVE TO INCARCERATION 

9 PROGRAMS. 

10 ‘‘(a) DEFINITIONS.—In this section— 

11 ‘‘(1) the term ‘eligible entity’ means a State, 

12 unit of local government, Indian tribe, or nonprofit 

13 organization; and 

14 ‘‘(2) the term ‘eligible participant’ means an in15 dividual who— 

16 ‘‘(A) comes into contact with the juvenile 

17 justice system or criminal justice system or is 

18 arrested or charged with an offense; 

19 ‘‘(B) has a history of or a current— 

20 ‘‘(i) substance use disorder; 

21 ‘‘(ii) mental illness; or 

22 ‘‘(iii) co-occurring mental illness and 

23 substance use disorders; and 

24 ‘‘(C) has been approved for participation in 

25 a program funded under this section by, as apVerDate Sep 11 2014 02:36 Feb 25, 2015 Jkt 049200 PO 00000 Frm 00023 Fmt 6652 Sfmt 6201 E:\BILLS\H953.IH H953

emcdonald on DSK67QTVN1PROD with BILLS
24 

•HR 953 IH

1 plicable depending on the stage of the criminal 

2 justice process, the relevant law enforcement 

3 agency or prosecuting attorney, defense attor4 ney, probation or corrections official, judge, or 

5 representative from the relevant mental health 

6 or substance abuse agency. 

7 ‘‘(b) PROGRAM AUTHORIZED.—The Attorney General 

8 may make grants to eligible entities to develop, implement, 

9 or expand a treatment alternative to incarceration pro10 gram for eligible participants, including— 

11 ‘‘(1) pre-booking treatment alternative to incar12 ceration programs, including— 

13 ‘‘(A) law enforcement training on sub14 stance use disorders, mental illness, and co-oc15 curring mental illness and substance use dis16 orders; 

17 ‘‘(B) receiving centers as alternatives to in18 carceration of eligible participants; 

19 ‘‘(C) specialized response units for calls re20 lated to substance use disorders, mental illness, 

21 and co-occurring mental illness and substance 

22 use disorders; and 

23 ‘‘(D) other arrest and pre-booking treat24 ment alternative to incarceration models; and 


emcdonald on DSK67QTVN1PROD with BILLS
25 

•HR 953 IH

1 ‘‘(2) post-booking treatment alternative to in2 carceration programs, including— 

3 ‘‘(A) specialized clinical case management; 

4 ‘‘(B) pre-trial services related to sub5 stances use disorders, mental illness, and co-oc6 curring mental illness and substance use dis7 orders; 

8 ‘‘(C) prosecutor and defender based pro9 grams; 

10 ‘‘(D) specialized probation; 

11 ‘‘(E) programs utilizing the American So12 ciety of Addiction Medicine patient placement 

13 criteria; 

14 ‘‘(F) treatment and rehabilitation pro15 grams and recovery support services; and 

16 ‘‘(G) drug courts, DWI courts, and vet17 erans treatment courts. 

18 ‘‘(c) APPLICATION.— 

19 ‘‘(1) IN GENERAL.—An eligible entity desiring a 

20 grant under this section shall submit an application 

21 to the Attorney General— 

22 ‘‘(A) that meets the criteria under para23 graph (2); and 


emcdonald on DSK67QTVN1PROD with BILLS
26 

•HR 953 IH

1 ‘‘(B) at such time, in such manner, and 

2 accompanied by such information as the Attor3 ney General may require. 

4 ‘‘(2) CRITERIA.—An eligible entity, in submit5 ting an application under paragraph (1), shall— 

6 ‘‘(A) provide extensive evidence of collabo7 ration with State and local government agencies 

8 overseeing health, community corrections, 

9 courts, prosecution, substance abuse, mental 

10 health, victims services, and employment serv11 ices, and with local law enforcement agencies; 

12 ‘‘(B) demonstrate consultation with the 

13 Single State Authority for Substance Abuse; 

14 ‘‘(C) demonstrate that evidence-based 

15 treatment practices will be utilized; and 

16 ‘‘(D) demonstrate that evidenced-based 

17 screening and assessment tools will be utilized 

18 to place participants in the treatment alter19 native to incarceration program. 

20 ‘‘(d) REQUIREMENTS.—Each eligible entity awarded 

21 a grant for a treatment alternative to incarceration pro22 gram under this section shall— 

23 ‘‘(1) determine the terms and conditions of par24 ticipation in the program by eligible participants, 


emcdonald on DSK67QTVN1PROD with BILLS
27 

•HR 953 IH

1 taking into consideration the collateral consequences 

2 of an arrest, prosecution, or criminal conviction; 

3 ‘‘(2) ensure that each substance abuse and 

4 mental health treatment component is licensed and 

5 qualified by the relevant jurisdiction; 

6 ‘‘(3) for programs described in subsection 

7 (b)(2), organize an enforcement unit comprised of 

8 appropriately trained law enforcement professionals 

9 under the supervision of the State, tribal, or local 

10 criminal justice agency involved, the duties of which 

11 shall include— 

12 ‘‘(A) the verification of addresses and 

13 other contacts of each eligible participant who 

14 participates or desires to participate in the pro15 gram; and 

16 ‘‘(B) if necessary, the location, apprehen17 sion, arrest, and return to court of an eligible 

18 participant in the program who has absconded 

19 from the facility of a treatment provider or has 

20 otherwise violated the terms and conditions of 

21 the program, consistent with Federal and State 

22 confidentiality requirements; 

23 ‘‘(4) notify the relevant criminal justice entity if 

24 any eligible participant in the program absconds 

25 from the facility of the treatment provider or otherVerDate Sep 11 2014 02:36 Feb 25, 2015 Jkt 049200 PO 00000 Frm 00027 Fmt 6652 Sfmt 6201 E:\BILLS\H953.IH H953

emcdonald on DSK67QTVN1PROD with BILLS
28 

•HR 953 IH

1 wise violates the terms and conditions of the pro2 gram, consistent with Federal and State confiden3 tiality requirements; 

4 ‘‘(5) submit periodic reports on the progress of 

5 treatment or other measured outcomes from partici6 pation in the program of each eligible offender par7 ticipating in the program to the relevant State, trib8 al, or local criminal justice agency; 

9 ‘‘(6) describe the evidence-based methodology 

10 and outcome measurements that will be used to 

11 evaluate the program, and specifically explain how 

12 such measurements will provide valid measures of 

13 the impact of the program; and 

14 ‘‘(7) describe how the program could be broadly 

15 replicated if demonstrated to be effective. 

16 ‘‘(e) USE OF FUNDS.—An eligible entity shall use a 

17 grant received under this section for expenses of a treat18 ment alternative to incarceration program, including— 

19 ‘‘(1) salaries, personnel costs, equipment costs, 

20 and other costs directly related to the operation of 

21 the program, including the enforcement unit; 

22 ‘‘(2) payments for treatment providers that are 

23 approved by the relevant State or tribal jurisdiction 

24 and licensed, if necessary, to provide needed treat25 ment to eligible offenders participating in the proVerDate Sep 11 2014 02:36 Feb 25, 2015 Jkt 049200 PO 00000 Frm 00028 Fmt 6652 Sfmt 6201 E:\BILLS\H953.IH H953

emcdonald on DSK67QTVN1PROD with BILLS
29 

•HR 953 IH

1 gram, including medication assisted treatment, 

2 aftercare supervision, vocational training, education, 

3 and job placement; and 

4 ‘‘(3) payments to public and nonprofit private 

5 entities that are approved by the State or tribal ju6 risdiction and licensed, if necessary, to provide alco7 hol and drug addiction treatment and mental health 

8 treatment to eligible offenders participating in the 

9 program. 

10 ‘‘(f) SUPPLEMENT NOT SUPPLANT.—An eligible enti11 ty shall use Federal funds received under this section only 

12 to supplement the funds that would, in the absence of 

13 those Federal funds, be made available from other Federal 

14 and non-Federal sources for the activities described in this 

15 section, and not to supplant those funds. 

16 ‘‘(g) GEOGRAPHIC DISTRIBUTION.—The Attorney 

17 General shall ensure that, to the extent practicable, the 

18 geographical distribution of grants under this section is 

19 equitable and includes a grant to an eligible entity in— 

20 ‘‘(1) each State; 

21 ‘‘(2) rural, suburban, and urban areas; and 

22 ‘‘(3) tribal jurisdictions. 

23 ‘‘(h) PRIORITY CONSIDERATION WITH RESPECT TO

24 STATES.—In awarding grants to States under this sec25 tion, the Attorney General shall give priority to a State 


emcdonald on DSK67QTVN1PROD with BILLS
30 

•HR 953 IH

1 that provides civil liability protection for first responders, 

2 health professionals, and family members administering 

3 naloxone to counteract opioid overdoses by— 

4 ‘‘(1) enacting legislation that provides such civil 

5 liability protection; or 

6 ‘‘(2) providing a certification by the attorney 

7 general of the State that the attorney general has— 

8 ‘‘(A) reviewed any applicable civil liability 

9 protection law to determine the applicability of 

10 the law with respect to first responders, health 

11 care professionals, family members, and other 

12 individuals who may administer naloxone to in13 dividuals reasonably believed to be suffering 

14 from opioid overdose; and 

15 ‘‘(B) concluded that the law described in 

16 subparagraph (A) provides adequate civil liabil17 ity protection applicable to such persons. 

18 ‘‘(i) REPORTS AND EVALUATIONS.— 

19 ‘‘(1) IN GENERAL.—Each fiscal year, each re20 cipient of a grant under this section during that fis21 cal year shall submit to the Attorney General a re22 port on the outcomes of activities carried out using 

23 that grant in such form, containing such informa24 tion, and on such dates as the Attorney General 

25 shall specify. 


emcdonald on DSK67QTVN1PROD with BILLS
31 

•HR 953 IH

1 ‘‘(2) CONTENTS.—A report submitted under 

2 paragraph (1) shall— 

3 ‘‘(A) describe best practices for treatment 

4 alternatives; and 

5 ‘‘(B) identify training requirements for law 

6 enforcement officers who participate in treat7 ment alternative to incarceration programs. 

8 ‘‘(j) AUTHORIZATION OF APPROPRIATIONS.—There 

9 are authorized to be appropriated to carry out this section 

10 $5,000,000 for each of fiscal years 2016 through 2020.’’. 

11 SEC. 202. LAW ENFORCEMENT NALOXONE TRAINING AND 

12 IMPLEMENTATION DEMONSTRATION. 

13 Part MM of the Omnibus Crime Control and Safe 

14 Streets Act of 1968, as amended by section 201, is amend15 ed by adding at the end the following: 

16 ‘‘SEC. 3035. LAW ENFORCEMENT NALOXONE TRAINING AND 

17 IMPLEMENTATION DEMONSTRATION. 

18 ‘‘(a) DEFINITION.—In this section, the term ‘eligible 

19 entity’ means a State, local, or tribal law enforcement 

20 agency. 

21 ‘‘(b) PROGRAM AUTHORIZED.—The Attorney Gen22 eral, in coordination with the Secretary of Health and 

23 Human Services and the Director of the Office of National 

24 Drug Control Policy, may make grants to eligible entities 


emcdonald on DSK67QTVN1PROD with BILLS
32 

•HR 953 IH

1 to create a demonstration law enforcement program to 

2 prevent opioid and heroin overdose death. 

3 ‘‘(c) APPLICATION.— 

4 ‘‘(1) IN GENERAL.—An eligible entity desiring a 

5 grant under this section shall submit an application 

6 to the Attorney General— 

7 ‘‘(A) that meets the criteria under para8 graph (2); and 

9 ‘‘(B) at such time, in such manner, and 

10 accompanied by such information as the Attor11 ney General may require. 

12 ‘‘(2) CRITERIA.—An eligible entity, in submit13 ting an application under paragraph (1), shall— 

14 ‘‘(A) describe the evidence-based method15 ology and outcome measurements that will be 

16 used to evaluate the program funded with a 

17 grant under this section, and specifically ex18 plain how such measurements will provide valid 

19 measures of the impact of the program; 

20 ‘‘(B) describe how the program could be 

21 broadly replicated if demonstrated to be effec22 tive; 

23 ‘‘(C) identify the governmental and com24 munity agencies that the program will coordi25 nate; and 


emcdonald on DSK67QTVN1PROD with BILLS
33 

•HR 953 IH

1 ‘‘(D) describe how law enforcement agen2 cies will coordinate with their corresponding 

3 State substance abuse and mental health agen4 cies to identify protocols and resources that are 

5 available to victims and families, including in6 formation on treatment and recovery resources. 

7 ‘‘(d) USE OF FUNDS.—An eligible entity shall use a 

8 grant received under this section to— 

9 ‘‘(1) make naloxone available to be carried and 

10 administered by law enforcement officers; 

11 ‘‘(2) train and provide resources for law en12 forcement officers on carrying and administering 

13 naloxone for the prevention of opioid and heroin 

14 overdose death; and 

15 ‘‘(3) establish processes, protocols, and mecha16 nisms for referral to treatment. 

17 ‘‘(e) GRANT AMOUNTS AND DURATION.— 

18 ‘‘(1) MAXIMUM AMOUNT.—The Attorney Gen19 eral may not award a grant under this section in an 

20 amount that exceeds $500,000. 

21 ‘‘(2) DURATION.—The Attorney General shall 

22 award grants under this section for a period not to 

23 exceed 2 years. 

24 ‘‘(f) TECHNICAL ASSISTANCE GRANTS.—The Attor25 ney General shall make a grant for the purpose of proVerDate Sep 11 2014 02:36 Feb 25, 2015 Jkt 049200 PO 00000 Frm 00033 Fmt 6652 Sfmt 6201 E:\BILLS\H953.IH H953

emcdonald on DSK67QTVN1PROD with BILLS
34 

•HR 953 IH

1 viding technical assistance and training on the use of 

2 naloxone to reverse overdose deaths and mechanisms for 

3 referral to treatment for an eligible entity receiving a 

4 grant under this section. 

5 ‘‘(g) EVALUATION.—The Attorney General shall con6 duct an evaluation of grants made under this section to 

7 determine— 

8 ‘‘(1) the number of officers equipped with 

9 naloxone for the prevention of fatal opioid and her10 oin overdose; 

11 ‘‘(2) the number of opioid and heroin overdoses 

12 reversed by officers receiving training and supplies 

13 of naloxone through a grant received under this sec14 tion; 

15 ‘‘(3) the number of calls for service related to 

16 opioid and heroin overdose; 

17 ‘‘(4) the extent to which overdose victims and 

18 families receive information about treatment services 

19 and available data describing treatment admissions; 

20 and 

21 ‘‘(5) the research, training, and naloxone supply 

22 needs of law enforcement and first responder agen23 cies, including those agencies that are not receiving 

24 grants under this section. 


emcdonald on DSK67QTVN1PROD with BILLS
35 

•HR 953 IH

1 ‘‘(h) AUTHORIZATION OF APPROPRIATIONS.—There 

2 are authorized to be appropriated to carry out this section 

3 $5,000,000 for each of fiscal years 2016 through 2020.’’. 

4 SEC. 203. PRESCRIPTION DRUG TAKE BACK EXPANSION. 

5 Part MM of the Omnibus Crime Control and Safe 

6 Streets Act of 1968, as amended by section 202, is amend7 ed by adding at the end the following: 

8 ‘‘SEC. 3036. PRESCRIPTION DRUG TAKE BACK EXPANSION. 

9 ‘‘(a) DEFINITION.—In this section, the term ‘eligible 

10 entity’ means— 

11 ‘‘(1) a State, local, or tribal law enforcement 

12 agency; 

13 ‘‘(2) a manufacturer, distributor, or reverse dis14 tributor of prescription medications; 

15 ‘‘(3) a retail pharmacy; 

16 ‘‘(4) a registered narcotic treatment program; 

17 ‘‘(5) a hospital or clinic with an on-site phar18 macy; 

19 ‘‘(6) an eligible long-term care facility; or 

20 ‘‘(7) any other entity authorized by the Drug 

21 Enforcement Administration to dispose of prescrip22 tion medications. 

23 ‘‘(b) PROGRAM AUTHORIZED.—The Attorney Gen24 eral, in coordination with the Administrator of the Drug 

25 Enforcement Administration, the Secretary of Health and 


emcdonald on DSK67QTVN1PROD with BILLS
36 

•HR 953 IH

1 Human Services, and the Director of the Office of Na2 tional Drug Control Policy, may make grants to eligible 

3 entities to expand or make available disposal sites for un4 wanted prescription medications. 

5 ‘‘(c) APPLICATION.— 

6 ‘‘(1) IN GENERAL.—An eligible entity desiring a 

7 grant under this section shall submit an application 

8 to the Attorney General— 

9 ‘‘(A) that meets the criteria under para10 graph (2); and 

11 ‘‘(B) at such time, in such manner, and 

12 accompanied by such information as the Attor13 ney General may require. 

14 ‘‘(2) CRITERIA.—An eligible entity, in submit15 ting an application under paragraph (1), shall— 

16 ‘‘(A) describe the evidence-based method17 ology and outcome measurements that will be 

18 used to evaluate the program funded with a 

19 grant under this section, and specifically ex20 plain how such measurements will provide valid 

21 measures of the impact of the program; 

22 ‘‘(B) describe how the program could be 

23 broadly replicated if demonstrated to be effec24 tive; and 


emcdonald on DSK67QTVN1PROD with BILLS
37 

•HR 953 IH

1 ‘‘(C) identify the governmental and com2 munity agencies that will coordinate the pro3 gram. 

4 ‘‘(d) USE OF FUNDS.—An eligible entity shall use a 

5 grant received under this section for— 

6 ‘‘(1) expenses of a prescription drug disposal 

7 site, including materials and resources; 

8 ‘‘(2) implementing disposal procedures and 

9 processes; 

10 ‘‘(3) implementing community education strate11 gies, including community education materials and 

12 resources; 

13 ‘‘(4) replicating a prescription drug take back 

14 initiative throughout multiple jurisdictions; and 

15 ‘‘(5) training of law enforcement officers and 

16 other community participants. 

17 ‘‘(e) GRANT AMOUNTS AND DURATION.— 

18 ‘‘(1) MAXIMUM AMOUNT.—The Attorney Gen19 eral may not award a grant under this section in an 

20 amount that exceeds $250,000. 

21 ‘‘(2) DURATION.—The Attorney General shall 

22 award grants under this section for a period not to 

23 exceed 2 years. 

24 ‘‘(f) TECHNICAL ASSISTANCE GRANT.—The Attorney 

25 General shall make a grant to a national nonprofit organiVerDate Sep 11 2014 02:36 Feb 25, 2015 Jkt 049200 PO 00000 Frm 00037 Fmt 6652 Sfmt 6201 E:\BILLS\H953.IH H953

emcdonald on DSK67QTVN1PROD with BILLS
38 

•HR 953 IH

1 zation to provide technical assistance and training for an 

2 eligible entity receiving a grant under this section. 

3 ‘‘(g) EVALUATION.— 

4 ‘‘(1) IN GENERAL.—The Attorney General shall 

5 make a grant for evaluation of the performance of 

6 each eligible entity receiving a grant under this sec7 tion. 

8 ‘‘(2) REPORTS.—Each fiscal year, the recipient 

9 of a grant under this subsection shall submit to the 

10 Attorney General a report that evaluates— 

11 ‘‘(A) the effectiveness of the prescription 

12 drug take back program of each eligible entity 

13 receiving a grant under this section; and 

14 ‘‘(B) the effect of disposal efforts on drug 

15 circulation. 

16 ‘‘(h) AUTHORIZATION OF APPROPRIATIONS.—There 

17 are authorized to be appropriated to carry out this section 

18 $2,500,000 for each of fiscal years 2016 through 2020.’’. 

19 TITLE III—TREATMENT AND 

20 RECOVERY 

21 SEC. 301. EVIDENCE-BASED OPIOID AND HEROIN TREAT22 MENT AND INTERVENTIONS DEMONSTRA23 TION. 

24 Subpart 1 of part B of title V of the Public Health 

25 Service Act (42 U.S.C. 290bb et seq.) is amended— 


emcdonald on DSK67QTVN1PROD with BILLS
39 

•HR 953 IH

1 (1) by redesignating section 514 (42 U.S.C. 

2 290bb–9), as added by section 3632 of the Meth3 amphetamine Anti-Proliferation Act of 2000 (Public 

4 Law 106–310; 114 Stat. 1236), as section 514B; 

5 and 

6 (2) by adding at the end the following: 

7 ‘‘SEC. 514C. EVIDENCE-BASED OPIOID AND HEROIN TREAT8 MENT AND INTERVENTIONS DEMONSTRA9 TION. 

10 ‘‘(a) GRANTS.— 

11 ‘‘(1) AUTHORITY TO MAKE GRANTS.—The Di12 rector of the Center for Substance Abuse Treatment 

13 (referred to in this section as the ‘Director’) may 

14 award grants to State substance abuse agencies, 

15 units of local government, nonprofit organizations, 

16 and Indian tribes or tribal organizations (as defined 

17 in section 4 of the Indian Health Care Improvement 

18 Act (25 U.S.C. 1603)) that have a high rate, or 

19 have had a rapid increase, in the use of heroin or 

20 other opioids, in order to permit such entities to ex21 pand activities, including an expansion in the avail22 ability of medication assisted treatment, with respect 

23 to the treatment of addiction in the specific geo24 graphical areas of such entities where there is a rate 


emcdonald on DSK67QTVN1PROD with BILLS
40 

•HR 953 IH

1 or rapid increase in the use of heroin or other 

2 opioids. 

3 ‘‘(2) RECIPIENTS.—The entities receiving 

4 grants under paragraph (1) shall be selected by the 

5 Director. 

6 ‘‘(3) NATURE OF ACTIVITIES.—The grant funds 

7 awarded under paragraph (1) shall be used for ac8 tivities that are based on reliable scientific evidence 

9 of efficacy in the treatment of problems related to 

10 heroin or other opioids. 

11 ‘‘(b) GEOGRAPHIC DISTRIBUTION.—The Director 

12 shall ensure that grants awarded under subsection (a) are 

13 distributed equitably among the various regions of the Na14 tion and among rural, urban, and suburban areas that are 

15 affected by the use of heroin or other opioids. 

16 ‘‘(c) ADDITIONAL ACTIVITIES.—The Director shall— 

17 ‘‘(1) evaluate the activities supported by grants 

18 awarded under subsection (a); 

19 ‘‘(2) disseminate widely such significant infor20 mation derived from the evaluation as the Director 

21 considers appropriate; 

22 ‘‘(3) provide States, Indian tribes and tribal or23 ganizations, and providers with technical assistance 

24 in connection with the provision of treatment of 

25 problems related to heroin and other opioids; and 


emcdonald on DSK67QTVN1PROD with BILLS
41 

•HR 953 IH

1 ‘‘(4) fund only those applications that specifi2 cally support recovery services as a critical compo3 nent of the grant program. 

4 ‘‘(d) DEFINITION.—The term ‘medication assisted 

5 treatment’ means the use, for problems relating to heroin 

6 and other opioids, of medications approved by the Food 

7 and Drug Administration in combination with counseling 

8 and behavioral therapies. 

9 ‘‘(e) AUTHORIZATION OF APPROPRIATIONS.— 

10 ‘‘(1) IN GENERAL.—There are authorized to be 

11 appropriated to carry out this section $12,000,000 

12 for fiscal year 2016 and such sums as may be nec13 essary for each of fiscal years 2016 through 2020. 

14 ‘‘(2) USE OF CERTAIN FUNDS.—Of the funds 

15 appropriated to carry out this section in any fiscal 

16 year, the lesser of 5 percent of such funds or 

17 $1,000,000 shall be available to the Director for 

18 purposes of carrying out subsection (c).’’. 

19 SEC. 302. CRIMINAL JUSTICE MEDICATION ASSISTED 

20 TREATMENT AND INTERVENTIONS DEM21 ONSTRATION. 

22 Part MM of the Omnibus Crime Control and Safe 

23 Streets Act of 1968, as amended by section 203, is amend24 ed by adding at the end the following: 


emcdonald on DSK67QTVN1PROD with BILLS
42 

•HR 953 IH

1 ‘‘SEC. 3037. CRIMINAL JUSTICE MEDICATION ASSISTED 

2 TREATMENT AND INTERVENTIONS DEM3 ONSTRATION. 

4 ‘‘(a) DEFINITIONS.—In this section— 

5 ‘‘(1) the term ‘criminal justice agency’ means a 

6 State, local, or tribal— 

7 ‘‘(A) court; 

8 ‘‘(B) prison; 

9 ‘‘(C) jail; or 

10 ‘‘(D) other agency that performs the ad11 ministration of criminal justice, including pros12 ecution, pretrial services, and community super13 vision; and 

14 ‘‘(2) the term ‘eligible entity’ means a State, 

15 unit of local government, or Indian tribe. 

16 ‘‘(b) PROGRAM AUTHORIZED.—The Attorney Gen17 eral, in coordination with the Secretary of Health and 

18 Human Services and the Director of the Office of National 

19 Drug Control Policy, may make grants to eligible entities 

20 to implement medication assisted treatment programs 

21 through criminal justice agencies. 

22 ‘‘(c) APPLICATION.— 

23 ‘‘(1) IN GENERAL.—An eligible entity desiring a 

24 grant under this section shall submit an application 

25 to the Attorney General— 


emcdonald on DSK67QTVN1PROD with BILLS
43 

•HR 953 IH

1 ‘‘(A) that meets the criteria under para2 graph (2); and 

3 ‘‘(B) at such time, in such manner, and 

4 accompanied by such information as the Attor5 ney General may require. 

6 ‘‘(2) CRITERIA.—An eligible entity, in submit7 ting an application under paragraph (1), shall— 

8 ‘‘(A) certify that each medication assisted 

9 treatment program funded with a grant under 

10 this section has been developed in consultation 

11 with the Single State Authority for Substance 

12 Abuse; and 

13 ‘‘(B) describe how data will be collected 

14 and analyzed to determine the effectiveness of 

15 the program described in subparagraph (A). 

16 ‘‘(d) USE OF FUNDS.—An eligible entity shall use a 

17 grant received under this section for expenses of— 

18 ‘‘(1) a medication assisted treatment program, 

19 including the expenses of prescribing medications 

20 recognized by the Food and Drug Administration for 

21 opioid treatment in conjunction with psychological 

22 and behavioral therapy; 

23 ‘‘(2) training criminal justice agency personnel 

24 and treatment providers on medication assisted 

25 treatment; 


emcdonald on DSK67QTVN1PROD with BILLS
44 

•HR 953 IH

1 ‘‘(3) cross-training personnel providing behav2 ioral health and health services, administration of 

3 medicines, and other administrative expenses, includ4 ing required reports; and 

5 ‘‘(4) the provision of recovery coaches who are 

6 responsible for providing mentorship and transition 

7 plans to individuals reentering society following in8 carceration or alternatives to incarceration. 

9 ‘‘(e) GRANT AMOUNTS AND DURATION.— 

10 ‘‘(1) MAXIMUM AMOUNT.—The Attorney Gen11 eral may not award a grant under this section in an 

12 amount that exceeds $750,000. 

13 ‘‘(2) DURATION.—The Attorney General shall 

14 award grants under this section for a period not to 

15 exceed 2 years. 

16 ‘‘(f) PRIORITY CONSIDERATION WITH RESPECT TO

17 STATES.—In awarding grants to States under this sec18 tion, the Attorney General shall give priority to a State 

19 that provides civil liability protection for first responders, 

20 health professionals, and family members administering 

21 naloxone to counteract opioid overdoses by— 

22 ‘‘(1) enacting legislation that provides such civil 

23 liability protection; or 

24 ‘‘(2) providing a certification by the attorney 

25 general of the State that the attorney general has— 


emcdonald on DSK67QTVN1PROD with BILLS
45 

•HR 953 IH

1 ‘‘(A) reviewed any applicable civil liability 

2 protection law to determine the applicability of 

3 the law with respect to first responders, health 

4 care professionals, family members, and other 

5 individuals who may administer naloxone to in6 dividuals reasonably believed to be suffering 

7 from opioid overdose; and 

8 ‘‘(B) concluded that the law described in 

9 subparagraph (A) provides adequate civil liabil10 ity protection applicable to such persons. 

11 ‘‘(g) TECHNICAL ASSISTANCE.—The Attorney Gen12 eral, in coordination with the Director of the National In13 stitute on Drug Abuse and the Secretary of Health and 

14 Human Services, shall provide technical assistance and 

15 training for an eligible entity receiving a grant under this 

16 section. 

17 ‘‘(h) REPORTS.— 

18 ‘‘(1) IN GENERAL.—An eligible entity receiving 

19 a grant under this subsection shall submit a report 

20 to the Attorney General on the outcomes of each 

21 grant received under this section for individuals re22 ceiving medication assisted treatment, based on— 

23 ‘‘(A) the recidivism of the individuals; 

24 ‘‘(B) the treatment outcomes of the indi25 viduals, including maintaining abstinence from 


emcdonald on DSK67QTVN1PROD with BILLS
46 

•HR 953 IH

1 illegal, unauthorized, and unprescribed or 

2 undispensed opioids and heroin; 

3 ‘‘(C) a comparison of the cost of providing 

4 medication assisted treatment to the cost of in5 carceration or other participation in the crimi6 nal justice system; 

7 ‘‘(D) the housing status of the individuals; 

8 and 

9 ‘‘(E) the employment status of the individ10 uals. 

11 ‘‘(2) CONTENTS AND TIMING.—Each report de12 scribed in paragraph (1) shall be submitted annually 

13 in such form, containing such information, and on 

14 such dates as the Attorney General shall specify. 

15 ‘‘(i) AUTHORIZATION OF APPROPRIATIONS.—There 

16 are authorized to be appropriated to carry out this section 

17 $5,000,000 for each of fiscal years 2016 through 2020.’’. 

18 SEC. 303. NATIONAL YOUTH RECOVERY INITIATIVE. 

19 (a) DEFINITIONS.—In this section: 

20 (1) ELIGIBLE ENTITY.—The term ‘‘eligible enti21 ty’’ means— 

22 (A) a high school that has been accredited 

23 as a recovery high school by the Association of 

24 Recovery Schools; 


emcdonald on DSK67QTVN1PROD with BILLS
47 

•HR 953 IH

1 (B) an accredited high school that is seek2 ing to establish or expand recovery support 

3 services; 

4 (C) an institution of higher education; 

5 (D) a recovery program at a nonprofit col6 legiate institution; or 

7 (E) a nonprofit organization. 

8 (2) INSTITUTION OF HIGHER EDUCATION.—The 

9 term ‘‘institution of higher education’’ has the 

10 meaning given the term in section 101 of the Higher 

11 Education Act of 1965 (20 U.S.C. 1001). 

12 (3) RECOVERY PROGRAM.—The term ‘‘recovery 

13 program’’— 

14 (A) means a program to help individuals 

15 who are recovering from substance use dis16 orders to initiate, stabilize, and maintain 

17 healthy and productive lives in the community; 

18 and 

19 (B) includes peer-to-peer support and com20 munal activities to build recovery skills and 

21 supportive social networks. 

22 (b) GRANTS AUTHORIZED.—The ONDCP Recovery 

23 Branch, in consultation with the Secretary of Education, 

24 may award grants to eligible entities to enable the entities 

25 to— 


emcdonald on DSK67QTVN1PROD with BILLS
48 

•HR 953 IH

1 (1) provide substance use recovery support serv2 ices to young people in high school and enrolled in 

3 institutions of higher education; 

4 (2) help build communities of support for young 

5 people in recovery through a spectrum of activities 

6 such as counseling and healthy and wellness-oriented 

7 social activities; and 

8 (3) encourage initiatives designed to help young 

9 people achieve and sustain recovery from substance 

10 use disorders. 

11 (c) USE OF FUNDS.—Grants awarded under sub12 section (b) may be used for activities to develop, support, 

13 and maintain youth recovery support services, including— 

14 (1) the development and maintenance of a dedi15 cated physical space for recovery programs; 

16 (2) dedicated staff for the provision of recovery 

17 programs; 

18 (3) healthy and wellness-oriented social activi19 ties and community engagement; 

20 (4) establishment of recovery high schools; 

21 (5) coordination of recovery programs with— 

22 (A) substance use disorder treatment pro23 grams and systems; 

24 (B) providers of mental health services; 

25 (C) primary care providers; 


emcdonald on DSK67QTVN1PROD with BILLS
49 

•HR 953 IH

1 (D) the criminal justice system, including 

2 the juvenile justice system; 

3 (E) employers; 

4 (F) housing services; 

5 (G) child welfare services; 

6 (H) institutions of secondary higher edu7 cation and institutions of higher education; and 

8 (I) other programs or services related to 

9 the welfare of an individual in recovery from a 

10 substance use disorder; 

11 (6) the development of peer-to-peer support 

12 programs or services; and 

13 (7) additional activities that help youths and 

14 young adults to achieve recovery from substance use 

15 disorders. 

16 (d) RESOURCE CENTER.—The ONDCP Recovery 

17 Branch shall establish a resource center to provide tech18 nical support to recipients of grants under this section. 

19 (e) AUTHORIZATION OF APPROPRIATIONS.—There 

20 are authorized to be appropriated to carry out this section 

21 $3,000,000 for fiscal year 2016 and each of the 5 suc22 ceeding fiscal years. 


emcdonald on DSK67QTVN1PROD with BILLS
50 

•HR 953 IH

1 SEC. 304. BUILDING COMMUNITIES OF RECOVERY. 

2 (a) DEFINITION.—In this section, the term ‘‘recovery 

3 community organization’’ means an independent nonprofit 

4 organization that— 

5 (1) mobilizes resources within and outside of 

6 the recovery community to increase the prevalence 

7 and quality of long-term recovery from substance 

8 use disorders; and 

9 (2) is wholly or principally governed by people 

10 in recovery for substance use disorders who reflect 

11 the community served. 

12 (b) GRANTS AUTHORIZED.—The ONDCP Recovery 

13 Branch, in consultation with the Substance Abuse and 

14 Mental Health Services Administration, may award grants 

15 to recovery community organizations to enable such orga16 nizations to develop, expand, and enhance recovery serv17 ices. 

18 (c) MAXIMUM GRANT AMOUNT.—The ONDCP Re19 covery Branch may not award a grant under this section 

20 in an amount that exceeds $200,000. 

21 (d) FEDERAL SHARE.—The Federal share of the 

22 costs of a program funded by a grant under this section 

23 may not exceed 50 percent. 

24 (e) USE OF FUNDS.—Grants awarded under sub25 section (b)— 


emcdonald on DSK67QTVN1PROD with BILLS
51 

•HR 953 IH

1 (1) shall be used to develop, expand, and en2 hance community and statewide recovery support 

3 services; and 

4 (2) may be used to— 

5 (A) advocate for individuals in recovery 

6 from substance use disorders; 

7 (B) build connections between recovery 

8 networks, between recovery community organi9 zations, and with other recovery support serv10 ices, including— 

11 (i) substance use disorder treatment 

12 programs and systems; 

13 (ii) providers of mental health serv14 ices; 

15 (iii) primary care providers; 

16 (iv) the criminal justice system; 

17 (v) employers; 

18 (vi) housing services; 

19 (vii) child welfare agencies; and 

20 (viii) other recovery support services 

21 that facilitate recovery from substance use 

22 disorders; 

23 (C) reduce the stigma associated with sub24 stance use disorders; 


emcdonald on DSK67QTVN1PROD with BILLS
52 

•HR 953 IH

1 (D) conduct public education and outreach 

2 on issues relating to substance use disorders 

3 and recovery, including— 

4 (i) how to identify the signs of addic5 tion; 

6 (ii) the resources that are available 

7 for individuals struggling with addiction; 

8 (iii) the resources that are available to 

9 help support individuals in recovery; and 

10 (iv) information on the medical con11 sequences of substance use disorders, in12 cluding neonatal abstinence syndrome and 

13 potential infection with human immuno14 deficiency virus and viral hepatitis; and 

15 (E) carry out other activities that 

16 strengthen the network of community support 

17 for individuals in recovery. 

18 (f) RESOURCE CENTER.—The ONDCP Recovery 

19 Branch shall establish a resource center to provide tech20 nical assistance to recipients of grants under this section 

21 and to provide information to individuals seeking to sup22 port people in recovery from substance use disorders. 

23 (g) AUTHORIZATION OF APPROPRIATIONS.—There 

24 are authorized to be appropriated to carry out this section 


emcdonald on DSK67QTVN1PROD with BILLS
53 

•HR 953 IH

1 $5,700,000 in fiscal year 2016 and each of the 3 suc2 ceeding fiscal years. 

3 TITLE IV—ADDRESSING 

4 COLLATERAL CONSEQUENCES 

5 SEC. 401. CORRECTIONAL EDUCATION DEMONSTRATION 

6 GRANT PROGRAM. 

7 Title I of the Omnibus Crime Control and Safe 

8 Streets Act of 1968 (42 U.S.C. 3711 et seq.) is amend9 ed— 

10 (1) by redesignating part KK as part LL; 

11 (2) by redesignating sections 3011 and 3012 as 

12 sections 3021 and 3022, respectively; and 

13 (3) by inserting before part LL, as redesig14 nated, the following: 

15 ‘‘PART KK—CORRECTIONAL EDUCATION 

16 DEMONSTRATION GRANT PROGRAM 

17 ‘‘SEC. 3011. CORRECTIONAL EDUCATION DEMONSTRATION 

18 GRANT PROGRAM. 

19 ‘‘(a) DEFINITION.—In this section, the term ‘eligible 

20 entity’ means a State, unit of local government, nonprofit 

21 organization, or Indian tribe. 

22 ‘‘(b) GRANT PROGRAM AUTHORIZED.—The Attorney 

23 General may make grants of not more than $750,000 to 

24 eligible entities to design, implement, and expand eduVerDate Sep 11 2014 02:36 Feb 25, 2015 Jkt 049200 PO 00000 Frm 00053 Fmt 6652 Sfmt 6201 E:\BILLS\H953.IH H953

emcdonald on DSK67QTVN1PROD with BILLS
54 

•HR 953 IH

1 cational programs for offenders in prisons, jails, and juve2 nile facilities, including to pay for— 

3 ‘‘(1) basic education, secondary level academic 

4 education, high school equivalency examination prep5 aration, career technical education, and English as 

6 a second language instruction at the basic, sec7 ondary, or post-secondary levels, for adult and juve8 nile populations; 

9 ‘‘(2) screening and assessment of inmates to as10 sess education level, needs, occupational interest or 

11 aptitude, risk level, and other needs, and case man12 agement services; 

13 ‘‘(3) hiring and training of instructors and 

14 aides, reimbursement of non-corrections staff and 

15 experts, reimbursement of stipends paid to inmate 

16 tutors or aides, and the costs of training inmate tu17 tors and aides; 

18 ‘‘(4) instructional supplies and equipment, in19 cluding occupational program supplies and equip20 ment to the extent that the supplies and equipment 

21 are used for instructional purposes; 

22 ‘‘(5) partnerships and agreements with commu23 nity colleges, universities, and career technology edu24 cation program providers, including tuition pay25 ments; 


emcdonald on DSK67QTVN1PROD with BILLS
55 

•HR 953 IH

1 ‘‘(6) certification programs providing recognized 

2 high school equivalency certificates and industry rec3 ognized credentials; and 

4 ‘‘(7) technology solutions to— 

5 ‘‘(A) meet the instructional, assessment, 

6 and information needs of correctional popu7 lations; and 

8 ‘‘(B) facilitate the continued participation 

9 of incarcerated students in community-based 

10 education programs after the students are re11 leased from incarceration. 

12 ‘‘(c) APPLICATION.—An eligible entity desiring a 

13 grant under this section shall submit to the Attorney Gen14 eral an application in such form and manner, at such time, 

15 and accompanied by such information as the Attorney 

16 General specifies. 

17 ‘‘(d) PRIORITY CONSIDERATIONS.—In awarding 

18 grants under this section, the Attorney General shall give 

19 priority to applicants that— 

20 ‘‘(1) assess the level of risk and need of in21 mates, including by— 

22 ‘‘(A) assessing the need for English as a 

23 second language instruction; 

24 ‘‘(B) conducting educational assessments; 

25 and 


emcdonald on DSK67QTVN1PROD with BILLS
56 

•HR 953 IH

1 ‘‘(C) assessing occupational interests and 

2 aptitudes; 

3 ‘‘(2) target educational services to assessed 

4 needs, including academic and occupational at the 

5 basic, secondary, or post-secondary level; 

6 ‘‘(3) target career technology education pro7 grams to— 

8 ‘‘(A) areas of identified occupational de9 mand; and 

10 ‘‘(B) employment opportunities in the com11 munities in which students are reasonably ex12 pected to reside post-release; 

13 ‘‘(4) include a range of appropriate educational 

14 opportunities at the basic, secondary, and post-sec15 ondary levels; 

16 ‘‘(5) include opportunities for students to attain 

17 industry recognized credentials; 

18 ‘‘(6) include partnership or articulation agree19 ments linking institutional education programs with 

20 community sited programs provided by adult edu21 cation program providers and accredited institutions 

22 of higher education, community colleges, and voca23 tional training institutions; and 

24 ‘‘(7) explicitly include career pathways models 

25 offering opportunities for incarcerated students to 


emcdonald on DSK67QTVN1PROD with BILLS
57 

•HR 953 IH

1 develop academic skills, in-demand occupational 

2 skills and credentials, occupational experience in in3 stitutional work programs or work release programs, 

4 and linkages with employers in the community, so 

5 that incarcerated students have opportunities to em6 bark on careers with strong prospects for both post7 release employment and advancement in a career 

8 ladder over time. 

9 ‘‘(e) REQUIREMENTS.—An eligible entity desiring a 

10 grant under this section shall— 

11 ‘‘(1) describe the evidence-based methodology 

12 and outcome measurements that will be used to 

13 evaluate each program funded with a grant under 

14 this section, and specifically explain how such meas15 urements will provide valid measures of the impact 

16 of the program; and 

17 ‘‘(2) describe how the program described in 

18 paragraph (1) could be broadly replicated if dem19 onstrated to be effective. 

20 ‘‘(f) CONTROL OF INTERNET ACCESS.—An entity 

21 that receives a grant under this section shall restrict ac22 cess to the Internet by prisoners, as appropriate, to ensure 

23 public safety. 


emcdonald on DSK67QTVN1PROD with BILLS
58 

•HR 953 IH

1 ‘‘SEC. 3012. AUTHORIZATION OF APPROPRIATIONS. 

2 ‘‘There are authorized to be appropriated $5,000,000 

3 to carry out this part for fiscal years 2016 through 

4 2020.’’. 

5 SEC. 402. REVISION OF FAFSA FORM. 

6 Section 483 of the Higher Education Act of 1965 (20 

7 U.S.C. 1090) is amended by adding at the end the fol8 lowing: 

9 ‘‘(i) CONVICTIONS.—The Secretary shall not include 

10 any question about the conviction of an applicant for the 

11 possession or sale of illegal drugs on the FAFSA (or any 

12 other form developed under subsection (a)).’’. 

13 SEC. 403. NATIONAL TASK FORCE ON RECOVERY AND COL14 LATERAL CONSEQUENCES. 

15 (a) DEFINITION.—In this section, the term ‘‘collat16 eral consequence’’ means a penalty, disability, or dis17 advantage— 

18 (1) imposed on an individual as a result of a 

19 criminal conviction but not as part of the judgment 

20 of the court that imposes the conviction; or 

21 (2) that an administrative agency, official, or 

22 civil court is authorized, but not required, to impose 

23 on an individual convicted of a felony, misdemeanor, 

24 or other criminal offense. 

25 (b) ESTABLISHMENT.— 


emcdonald on DSK67QTVN1PROD with BILLS
59 

•HR 953 IH

1 (1) IN GENERAL.—Not later than 30 days after 

2 the date of enactment of this Act, the Secretary of 

3 Health and Human Services (in this section referred 

4 to as the ‘‘Secretary’’) shall establish a bipartisan 

5 task force to be known as the Task Force on Recov6 ery and Collateral Consequences (in this section re7 ferred to as the ‘‘Task Force’’). 

8 (2) MEMBERSHIP.— 

9 (A) TOTAL NUMBER OF MEMBERS.—The 

10 Task Force shall include 10 members, who shall 

11 be appointed by the Secretary in accordance 

12 with subparagraphs (B) and (C). 

13 (B) MEMBERS OF THE TASK FORCE.—The 

14 Task Force shall include— 

15 (i) members who have national rec16 ognition and significant expertise in areas 

17 such as health care, housing, employment, 

18 substance use disorder, mental health, law 

19 enforcement, and law; 

20 (ii) not fewer than 2 members— 

21 (I) who have personally experi22 enced substance abuse or addiction 

23 and are in recovery; and 


emcdonald on DSK67QTVN1PROD with BILLS
60 

•HR 953 IH

1 (II) not fewer than 1 one of 

2 whom has benefited from medication 

3 assisted treatment; and 

4 (iii) to the extent practicable, mem5 bers who formerly served as elected offi6 cials at the State and Federal levels. 

7 (C) TIMING.—The Secretary shall appoint 

8 the members of the Task Force not later than 

9 60 days after the date on which the Task Force 

10 is established under paragraph (1). 

11 (3) CHAIRPERSON.—The Task Force shall se12 lect a chairperson or co-chairpersons from among 

13 the members of the Task Force. 

14 (c) DUTIES OF THE TASK FORCE.— 

15 (1) IN GENERAL.—The Task Force shall— 

16 (A) identify collateral consequences for in17 dividuals with Federal or State drug convictions 

18 who are in recovery for substance use disorder; 

19 and 

20 (B) determine whether the collateral con21 sequences identified under subparagraph (A) 

22 unnecessarily delay individuals in recovery from 

23 resuming their personal and professional activi24 ties. 


emcdonald on DSK67QTVN1PROD with BILLS
61 

•HR 953 IH

1 (2) RECOMMENDATIONS.—Not later than 180 

2 days after the date of the first meeting of the Task 

3 Force, the Task Force shall develop recommenda4 tions for proposed legislative and regulatory changes 

5 to reduce and, to the extent practicable, eliminate 

6 the collateral consequences identified by the Task 

7 Force under paragraph (1). 

8 (3) COLLECTION OF INFORMATION.—The Task 

9 Force shall hold hearings, require the testimony and 

10 attendance of witnesses, and secure information 

11 from any department or agency of the United States 

12 in performing the duties under paragraphs (1) and 

13 (2). 

14 (4) REPORT.—Not later than 1 year after the 

15 date of the first meeting of the Task Force, the 

16 Task Force shall submit a report detailing the find17 ings and recommendations of the Task Force to— 

18 (A) each relevant committee of Congress; 

19 (B) the head of each relevant department 

20 or agency of the United States; 

21 (C) the President; and 

22 (D) the Vice President. 


emcdonald on DSK67QTVN1PROD with BILLS
62 

•HR 953 IH

1 TITLE V—ADDICTION AND 

2 TREATMENT SERVICES FOR 

3 WOMEN, FAMILIES, AND VET4 ERANS 

5 SEC. 501. AUTHORITY TO AWARD COMPETITIVE GRANTS TO 

6 ADDRESS OPIOID AND HEROIN ABUSE BY 

7 PREGNANT AND PARENTING FEMALE OF8 FENDERS. 

9 Part MM of the Omnibus Crime Control and Safe 

10 Streets Act of 1968, as amended by section 302, is amend11 ed by adding at the end the following: 

12 ‘‘SEC. 3038. AUTHORITY TO AWARD COMPETITIVE GRANTS 

13 TO ADDRESS OPIOID AND HEROIN ABUSE BY 

14 PREGNANT AND PARENTING FEMALE OF15 FENDERS. 

16 ‘‘(a) DEFINITIONS.—In this section— 

17 ‘‘(1) the term ‘State criminal justice agency’ 

18 means the agency of the State responsible for ad19 ministering criminal justice funds, including the Ed20 ward Byrne Memorial Justice Assistance Grant Pro21 gram under subpart 1 of part E; and 

22 ‘‘(2) the term ‘State substance abuse agency’ 

23 means the agency of the State responsible for the 

24 State prevention, treatment, and recovery system, 

25 including management of the Substance Abuse PreVerDate Sep 11 2014 02:36 Feb 25, 2015 Jkt 049200 PO 00000 Frm 00062 Fmt 6652 Sfmt 6201 E:\BILLS\H953.IH H953

emcdonald on DSK67QTVN1PROD with BILLS
63 

•HR 953 IH

1 vention and Treatment Block Grant under subpart 

2 II of part B of title XIX of the Public Health Serv3 ice Act (42 U.S.C. 300x–21 et seq.). 

4 ‘‘(b) PURPOSE AND PROGRAM AUTHORITY.— 

5 ‘‘(1) GRANT AUTHORIZATION.—The Attorney 

6 General, in coordination with the Secretary of 

7 Health and Human Services, may award competitive 

8 grants jointly to a State substance abuse agency and 

9 a State criminal justice agency to address the use of 

10 opioids and heroin among pregnant and parenting 

11 female offenders in the State to promote public safe12 ty, public health, family permanence, and well-being. 

13 ‘‘(2) PURPOSES AND PROGRAM AUTHORITY.—A 

14 grant under this section shall be used to facilitate or 

15 enhance collaboration between the State criminal 

16 justice and State substance abuse systems in order 

17 to carry out programs to address the use of opioid 

18 and heroin abuse by pregnant and parenting female 

19 offenders. 

20 ‘‘(c) APPLICATIONS.— 

21 ‘‘(1) IN GENERAL.—A State substance abuse 

22 agency and State criminal justice agency desiring a 

23 grant under this section shall jointly submit to the 

24 Attorney General an application in such form, and 


emcdonald on DSK67QTVN1PROD with BILLS
64 

•HR 953 IH

1 containing such information, as the Attorney Gen2 eral may prescribe by regulation or guidelines. 

3 ‘‘(2) CONTENTS.— 

4 ‘‘(A) IN GENERAL.—Each application for a 

5 grant under this section shall contain a plan to 

6 expand the services of the State for pregnant 

7 and parenting female offenders for the use of 

8 opioids, heroin, and other drugs, which shall be 

9 in accordance with regulations or guidelines es10 tablished by the Attorney General, in consulta11 tion with the Secretary of Health and Human 

12 Services. 

13 ‘‘(B) PLAN.—A plan submitted under sub14 paragraph (A) shall, at a minimum, include— 

15 ‘‘(i) a description of how the appli16 cants will work jointly to address the needs 

17 associated with the use of opioids or heroin 

18 by pregnant and parenting female offend19 ers to promote family stability and perma20 nence; 

21 ‘‘(ii) a description of the nature and 

22 the extent of the problem of opioid and 

23 heroin use by pregnant and parenting fe24 male offenders in the State; 


emcdonald on DSK67QTVN1PROD with BILLS
65 

•HR 953 IH

1 ‘‘(iii) a certification that the State has 

2 involved counties and other units of local 

3 government, when appropriate, in the de4 velopment, expansion, modification, oper5 ation, or improvement of proposed pro6 grams to address the problems associated 

7 with opioid and heroin use; 

8 ‘‘(iv) a certification that funds re9 ceived under this section will be used to 

10 supplement, not supplant, other Federal, 

11 State, and local funds; and 

12 ‘‘(v) a description of clinically appro13 priate practices and procedures to— 

14 ‘‘(I) screen and assess pregnant 

15 and parenting female offenders for 

16 problems associated with opioids and 

17 heroin; 

18 ‘‘(II) screen and assess pregnant 

19 and parenting female offenders dem20 onstrating problems associated with 

21 opioids and heroin for co-occurring 

22 mental disorders; 

23 ‘‘(III) provide clinically appro24 priate services, including medication 

25 assisted treatment, for female offendVerDate Sep 11 2014 02:36 Feb 25, 2015 Jkt 049200 PO 00000 Frm 00065 Fmt 6652 Sfmt 6201 E:\BILLS\H953.IH H953

emcdonald on DSK67QTVN1PROD with BILLS
66 

•HR 953 IH

1 ers and their children in the same lo2 cation to promote family permanence 

3 and self-sufficiency; and 

4 ‘‘(IV) provide for a process to en5 hance or ensure the abilities of the 

6 State criminal justice agency and 

7 State substance abuse agency to work 

8 together to reunite families when ap9 propriate in the case where family 

10 treatment is not provided. 

11 ‘‘(d) PERIOD OF GRANT; RENEWAL.— 

12 ‘‘(1) PERIOD.—A grant under this section shall 

13 be for a period of 3 years. 

14 ‘‘(2) RENEWAL.—A State substance abuse 

15 agency and a State criminal justice agency receiving 

16 a grant under this section may apply for and, after 

17 the end of the period of the first grant under this 

18 section, receive 1 additional grant under this section. 

19 ‘‘(e) PERFORMANCE ACCOUNTABILITY; REPORTS.— 

20 ‘‘(1) REPORTS.—A State substance abuse agen21 cy and a State criminal justice agency receiving a 

22 grant under this section shall jointly submit to the 

23 Attorney General a report on the activities carried 

24 out under the grant at the end of each fiscal year 

25 during the period of the grant. 


emcdonald on DSK67QTVN1PROD with BILLS
67 

•HR 953 IH

1 ‘‘(2) EVALUATION.—Not later than 1 year after 

2 the end of the period of a grant under this section, 

3 the Attorney General shall submit a report to each 

4 committee of Congress with jurisdiction of the pro5 gram under this section that summarizes the reports 

6 of the recipients of the grant and provides rec7 ommendations, if any, for further legislative action. 

8 ‘‘(f) TRAINING AND TECHNICAL ASSISTANCE.—The 

9 Attorney General shall support State substance abuse and 

10 State criminal justice agencies by developing, in consulta11 tion with State substance abuse and State criminal justice 

12 agencies, and offering a program of training and technical 

13 assistance to assist the agencies in developing programs 

14 and protocols— 

15 ‘‘(1) to implement this section; and 

16 ‘‘(2) for effectively working across the Federal 

17 and State criminal and substance abuse systems. 

18 ‘‘(g) AUTHORIZATION OF APPROPRIATIONS.—There 

19 are authorized to be appropriated to carry out this section 

20 $5,000,000 for each of fiscal years 2016 through 2020.’’. 

21 SEC. 502. GRANTS FOR FAMILY-BASED SUBSTANCE ABUSE 

22 TREATMENT. 

23 Section 2925 of the Omnibus Crime Control and Safe 

24 Streets Act of 1968 (42 U.S.C. 3797s–4) is amended— 


emcdonald on DSK67QTVN1PROD with BILLS
68 

•HR 953 IH

1 (1) by striking ‘‘An entity’’ and inserting ‘‘(a) 

2 ENTITY REPORTS.—An entity’’; and 

3 (2) by adding at the end the following: 

4 ‘‘(b) ATTORNEY GENERAL REPORT ON FAMILY5 BASED SUBSTANCE ABUSE TREATMENT.—The Attorney 

6 General shall submit to Congress an annual report that 

7 describes the number of grants awarded under section 

8 2921(1) and how such grants are used by the recipients 

9 for family-based substance abuse treatment programs that 

10 serve as alternatives to incarceration for custodial parents 

11 to receive treatment and services as a family.’’. 

12 SEC. 503. VETERANS’ TREATMENT COURTS. 

13 Section 2991 of the Omnibus Crime Control and Safe 

14 Streets Act of 1968 (42 U.S.C. 3797aa) is amended— 

15 (1) by redesignating subsection (i) as subsection 

16 (j); 

17 (2) by inserting after subsection (h) the fol18 lowing: 

19 ‘‘(i) ASSISTING VETERANS.— 

20 ‘‘(1) DEFINITIONS.—In this subsection: 

21 ‘‘(A) PEER TO PEER SERVICES OR PRO22 GRAMS.—The term ‘peer to peer services or 

23 programs’ means services or programs that con24 nect qualified veterans with other veterans for 

25 the purpose of providing support and 


emcdonald on DSK67QTVN1PROD with BILLS
69 

•HR 953 IH

1 mentorship to assist qualified veterans in ob2 taining treatment, recovery, stabilization, or re3 habilitation. 

4 ‘‘(B) QUALIFIED VETERAN.—The term 

5 ‘qualified veteran’ means a preliminarily quali6 fied offender who— 

7 ‘‘(i) has served on active duty in any 

8 branch of the Armed Forces, including the 

9 National Guard and reserve components; 

10 and 

11 ‘‘(ii)(I) was discharged or released 

12 from such service under conditions other 

13 than dishonorable; or 

14 ‘‘(II) was discharged or released from 

15 such service under dishonorable conditions, 

16 if the reason for that discharge or release, 

17 if known, is attributable to drug use. 

18 ‘‘(C) VETERANS TREATMENT COURT PRO19 GRAM.—The term ‘veterans treatment court 

20 program’ means a court program involving col21 laboration among criminal justice, veterans, and 

22 mental health and substance abuse agencies 

23 that provides qualified veterans with— 

24 ‘‘(i) intensive judicial supervision and 

25 case management, which may include ranVerDate Sep 11 2014 02:36 Feb 25, 2015 Jkt 049200 PO 00000 Frm 00069 Fmt 6652 Sfmt 6201 E:\BILLS\H953.IH H953

emcdonald on DSK67QTVN1PROD with BILLS
70 

•HR 953 IH

1 dom and frequent drug testing where ap2 propriate; 

3 ‘‘(ii) a full continuum of treatment 

4 services, including mental health services, 

5 substance abuse services, medical services, 

6 and services to address trauma; 

7 ‘‘(iii) alternatives to incarceration; 

8 and 

9 ‘‘(iv) other appropriate services, in10 cluding housing, transportation, mentoring, 

11 employment, job training, education, and 

12 assistance in applying for and obtaining 

13 available benefits. 

14 ‘‘(2) VETERANS ASSISTANCE PROGRAM.— 

15 ‘‘(A) IN GENERAL.—The Attorney General, 

16 in consultation with the Secretary of Veterans 

17 Affairs, may award grants under this sub18 section to applicants to establish or expand— 

19 ‘‘(i) veterans treatment court pro20 grams; 

21 ‘‘(ii) peer to peer services or programs 

22 for qualified veterans; 

23 ‘‘(iii) practices that identify and pro24 vide treatment, rehabilitation, legal, transi25 tional, and other appropriate services to 


emcdonald on DSK67QTVN1PROD with BILLS
71 

•HR 953 IH

1 qualified veterans who have been incarcer2 ated; and 

3 ‘‘(iv) training programs to teach 

4 criminal justice, law enforcement, correc5 tions, mental health, and substance abuse 

6 personnel how to identify and appro7 priately respond to incidents involving 

8 qualified veterans. 

9 ‘‘(B) PRIORITY.—In awarding grants 

10 under this subsection, the Attorney General 

11 shall give priority to applications that— 

12 ‘‘(i) demonstrate collaboration be13 tween and joint investments by criminal 

14 justice, mental health, substance abuse, 

15 and veterans service agencies; 

16 ‘‘(ii) promote effective strategies to 

17 identify and reduce the risk of harm to 

18 qualified veterans and public safety; and 

19 ‘‘(iii) propose interventions with em20 pirical support to improve outcomes for 

21 qualified veterans.’’; and 

22 (3) in subsection (j), as so redesignated— 

23 (A) by redesignating paragraph (2) as 

24 paragraph (3); and 


emcdonald on DSK67QTVN1PROD with BILLS
72 

•HR 953 IH

1 (B) by inserting after paragraph (1) the 

2 following: 

3 ‘‘(2) VETERANS TREATMENT COURTS.—In addi4 tion to the amounts authorized under paragraph (1), 

5 there are authorized to be appropriated to the Attor6 ney General $5,000,000 for each of fiscal years 

7 2016 through 2020 to carry out subsection (i).’’. 

8 TITLE VI—INCENTIVIZING STATE 

9 COMPREHENSIVE INITIA10 TIVES TO ADDRESS OPIOID 

11 AND HEROIN ABUSE 

12 SEC. 601. STATE DEMONSTRATION GRANTS FOR COM13 PREHENSIVE OPIOID ABUSE RESPONSE. 

14 Part MM of the Omnibus Crime Control and Safe 

15 Streets Act of 1968, as amended by section 501, is amend16 ed by adding at the end the following: 

17 ‘‘SEC. 3039. STATE DEMONSTRATION GRANTS FOR COM18 PREHENSIVE OPIOID ABUSE RESPONSE. 

19 ‘‘(a) DEFINITIONS.—In this section— 

20 ‘‘(1) the term ‘dispenser’ has the meaning given 

21 the term in section 102 of the Controlled Substances 

22 Act (21 U.S.C. 802); 

23 ‘‘(2) the term ‘prescriber of a schedule II, III, 

24 or IV controlled substance’ does not include a preVerDate Sep 11 2014 02:36 Feb 25, 2015 Jkt 049200 PO 00000 Frm 00072 Fmt 6652 Sfmt 6201 E:\BILLS\H953.IH H953

emcdonald on DSK67QTVN1PROD with BILLS
73 

•HR 953 IH

1 scriber of a schedule II, III, or IV controlled sub2 stance that dispenses the substance— 

3 ‘‘(A) for use on the premises on which the 

4 substance is dispensed; 

5 ‘‘(B) in a hospital emergency room, when 

6 the substance is in short supply; 

7 ‘‘(C) for a certified opioid treatment pro8 gram; or 

9 ‘‘(D) in other situations as the Attorney 

10 General may reasonably determine; 

11 ‘‘(3) the term ‘prescriber’ means a dispenser 

12 who prescribes a controlled substance, or the agent 

13 of such a dispenser; and 

14 ‘‘(4) the term ‘schedule II, III, or IV controlled 

15 substance’ means a controlled substance that is list16 ed on schedule II, schedule III, or schedule IV of 

17 section 202(c) of the Controlled Substances Act (21 

18 U.S.C. 812(c)). 

19 ‘‘(b) PLANNING AND IMPLEMENTATION GRANTS.— 

20 ‘‘(1) IN GENERAL.—The Attorney General, in 

21 coordination with the Secretary of Health and 

22 Human Services and the Director of the Office of 

23 National Drug Control Policy, may award grants to 

24 States, and combinations thereof, to prepare a comVerDate Sep 11 2014 02:36 Feb 25, 2015 Jkt 049200 PO 00000 Frm 00073 Fmt 6652 Sfmt 6201 E:\BILLS\H953.IH H953

emcdonald on DSK67QTVN1PROD with BILLS
74 

•HR 953 IH

1 prehensive plan for and implement an integrated 

2 opioid abuse response initiative. 

3 ‘‘(2) PURPOSES.—A State receiving a grant 

4 under this section shall establish a comprehensive 

5 response to opioid abuse, which shall include— 

6 ‘‘(A) prevention and education efforts 

7 around heroin and opioid use, treatment, and 

8 recovery; 

9 ‘‘(B) a comprehensive prescription drug 

10 monitoring program to track dispensing of 

11 schedule II, III, or IV controlled substances, 

12 which shall include— 

13 ‘‘(i) data sharing with other States by 

14 statute, regulation, or interstate agree15 ment; and 

16 ‘‘(ii) educating physicians, residents, 

17 medical students, and other prescribers of 

18 Schedule II, III, or IV controlled sub19 stances on the prescription drug moni20 toring program of the State; 

21 ‘‘(C) developing, implementing, or expand22 ing the prescription drug and opioid addiction 

23 treatment program of the State by— 

24 ‘‘(i) expanding programs for medica25 tion assisted treatment of prescription 


emcdonald on DSK67QTVN1PROD with BILLS
75 

•HR 953 IH

1 drug and opioid addiction, including train2 ing for treatment and recovery support 

3 providers; 

4 ‘‘(ii) developing, implementing, or ex5 panding programs for behavioral health 

6 therapy for individuals who are in treat7 ment for prescription drug and opioid ad8 diction, including contingency manage9 ment, cognitive behavioral therapy, and 

10 motivational enhancements; 

11 ‘‘(iii) developing, implementing, or ex12 panding programs to screen individuals 

13 who are in treatment for prescription drug 

14 and opioid addiction for hepatitis C and 

15 HIV, and provide treatment for those indi16 viduals if clinically appropriate; or 

17 ‘‘(iv) developing, implementing, or ex18 panding programs that provide screening, 

19 early intervention, and referral to treat20 ment (commonly referred to as ‘SBIRT’) 

21 to teenagers and young adults in primary 

22 care, middle schools, high schools, univer23 sities, school-based health centers, and 

24 other community-based health care settings 


emcdonald on DSK67QTVN1PROD with BILLS
76 

•HR 953 IH

1 frequently accessed by teenagers or young 

2 adults; and 

3 ‘‘(D) developing, implementing, and ex4 panding programs to prevent overdose death of 

5 prescription medications and opioids. 

6 ‘‘(3) PLANNING GRANT APPLICATIONS.— 

7 ‘‘(A) APPLICATION.— 

8 ‘‘(i) IN GENERAL.—A State desiring a 

9 planning grant under this section to pre10 pare a comprehensive plan for an inte11 grated opioid abuse response initiative 

12 shall submit to the Attorney General an 

13 application in such form, and containing 

14 such information, as the Attorney General 

15 may prescribe by regulation or guidelines. 

16 ‘‘(ii) REQUIREMENTS.—An application 

17 for a planning grant under this section 

18 shall, at a minimum, include— 

19 ‘‘(I) a budget and a budget jus20 tification for the activities to be car21 ried out using the grant; 

22 ‘‘(II) a description of the activi23 ties proposed to be carried out using 

24 the grant, including a schedule for 

25 completion of such activities; 


emcdonald on DSK67QTVN1PROD with BILLS
77 

•HR 953 IH

1 ‘‘(III) outcome measures that will 

2 be used to measure the effectiveness 

3 of the programs and initiatives to ad4 dress opioids; and 

5 ‘‘(IV) a description of the per6 sonnel necessary to complete such ac7 tivities. 

8 ‘‘(B) PERIOD; NONRENEWABILITY.—A 

9 planning grant under this section shall be for a 

10 period of 1 year. A State may not receive more 

11 than 1 planning grant under this section. 

12 ‘‘(C) AMOUNT.—A planning grant under 

13 this section may not exceed $100,000, except 

14 that the Attorney General may, for good cause, 

15 approve a grant in a higher amount. 

16 ‘‘(D) STRATEGIC PLAN AND PROGRAM IM17 PLEMENTATION PLAN.—A State receiving a 

18 planning grant under this section shall develop 

19 a strategic plan and a program implementation 

20 plan. 

21 ‘‘(4) IMPLEMENTATION GRANTS.— 

22 ‘‘(A) APPLICATION.—A State desiring an 

23 implementation grant under this section to im24 plement a comprehensive strategy for address25 ing opioid abuse shall submit to the Attorney 


emcdonald on DSK67QTVN1PROD with BILLS
78 

•HR 953 IH

1 General an application in such form, and con2 taining such information, as the Attorney Gen3 eral may prescribe by regulation or guidelines. 

4 ‘‘(B) USE OF FUNDS.—A State that re5 ceives an implementation grant under this sec6 tion shall use the grant for the cost of carrying 

7 out an integrated opioid abuse response pro8 gram in accordance with this section, including 

9 for technical assistance, training, and adminis10 trative expenses. 

11 ‘‘(C) REQUIREMENTS.—An integrated 

12 opioid abuse response program carried out 

13 using an implementation grant under this sec14 tion shall— 

15 ‘‘(i) ensure that each prescriber of a 

16 schedule II, III, or IV controlled substance 

17 in the State— 

18 ‘‘(I) registers with the prescrip19 tion drug monitoring program of the 

20 State; and 

21 ‘‘(II) consults the prescription 

22 drug monitoring program database of 

23 the State before prescribing a sched24 ule II, III, or IV controlled substance; 


emcdonald on DSK67QTVN1PROD with BILLS
79 

•HR 953 IH

1 ‘‘(ii) ensure that each dispenser of a 

2 schedule II, III, or IV controlled substance 

3 in the State— 

4 ‘‘(I) registers with the prescrip5 tion drug monitoring program of the 

6 State; 

7 ‘‘(II) consults the prescription 

8 drug monitoring program database of 

9 the State before dispensing a schedule 

10 II, III, or IV controlled substance; 

11 and 

12 ‘‘(III) reports to the prescription 

13 drug monitoring program of the 

14 State, at a minimum, each instance in 

15 which a schedule II, III, or IV con16 trolled substance is dispensed, with 

17 limited exceptions, as defined by the 

18 State, which shall indicate the pre19 scriber by name and National Pro20 vider Identifier; 

21 ‘‘(iii) require that, not fewer than 4 

22 times each year, the State agency or agen23 cies that administer the prescription drug 

24 monitoring program of the State prepare 

25 and provide to each prescriber of a schedVerDate Sep 11 2014 02:36 Feb 25, 2015 Jkt 049200 PO 00000 Frm 00079 Fmt 6652 Sfmt 6201 E:\BILLS\H953.IH H953

emcdonald on DSK67QTVN1PROD with BILLS
80 

•HR 953 IH

1 ule II, III, or IV controlled substance an 

2 informational report that shows how the 

3 prescribing patterns of the prescriber com4 pare to prescribing practices of the peers 

5 of the prescriber and expected norms; 

6 ‘‘(iv) if informational reports provided 

7 to a prescriber under clause (iii) indicate 

8 that the prescriber is repeatedly falling 

9 outside of expected norms or standard 

10 practices for the prescriber’s field, direct 

11 the prescriber to educational resources on 

12 appropriate prescribing of controlled sub13 stances; 

14 ‘‘(v) ensure that the prescriber licens15 ing board of the State receives a report de16 scribing any prescribers that repeatedly 

17 fall outside of expected norms or standard 

18 practices for the prescriber’s field, as de19 scribed in clause (iii); 

20 ‘‘(vi) require consultation with the 

21 Single State Authority for Substance 

22 Abuse; and 

23 ‘‘(vii) establish requirements for how 

24 data will be collected and analyzed to de25 termine the effectiveness of the program. 


emcdonald on DSK67QTVN1PROD with BILLS
81 

•HR 953 IH

1 ‘‘(D) PERIOD.—An implementation grant 

2 under this section shall be for a period of 2 

3 years. 

4 ‘‘(E) AMOUNT.—The amount of an imple5 mentation grant under this section may not ex6 ceed $5,000,000 except that the Attorney Gen7 eral may, for good cause, approve a grant in a 

8 higher amount. 

9 ‘‘(5) PRIORITY CONSIDERATIONS.—In awarding 

10 planning and implementation grants under this sec11 tion, the Attorney General shall give priority to a 

12 State that— 

13 ‘‘(A) provides civil liability protection for 

14 first responders, health professionals, and fam15 ily members administering naloxone to counter16 act opioid overdoses by— 

17 ‘‘(i) enacting legislation that provides 

18 such civil liability protection; or 

19 ‘‘(ii) providing a certification by the 

20 attorney general of the State that the at21 torney general has— 

22 ‘‘(I) reviewed any applicable civil 

23 liability protection law to determine 

24 the applicability of the law with re25 spect to first responders, health care 


emcdonald on DSK67QTVN1PROD with BILLS
82 

•HR 953 IH

1 professionals, family members, and 

2 other individuals who may administer 

3 naloxone to individuals reasonably be4 lieved to be suffering from opioid 

5 overdose; and 

6 ‘‘(II) concluded that the law de7 scribed in subclause (I) provides ade8 quate civil liability protection applica9 ble to such persons; 

10 ‘‘(B) have in effect legislation or imple11 ment a policy under which the State shall not 

12 terminate, but may suspend, enrollment under 

13 the State plan for medical assistance under title 

14 XIX of the Social Security Act (42 U.S.C. 1396 

15 et seq.) for an individual who is incarcerated for 

16 a period of fewer than 2 years; 

17 ‘‘(C) have a process for enrollment in serv18 ices and benefits necessary by criminal justice 

19 agencies to initiate or continue treatment in the 

20 community, under which an individual who is 

21 incarcerated may, while incarcerated, enroll in 

22 services and benefits that are necessary for the 

23 individual to continue treatment upon release 

24 from incarceration; 


emcdonald on DSK67QTVN1PROD with BILLS
83 

•HR 953 IH

1 ‘‘(D) ensures the capability of data sharing 

2 with other States, such as by making data 

3 available to a prescription monitoring hub; 

4 ‘‘(E) ensures that data recorded in the 

5 prescription drug monitoring program database 

6 of the State is available within 24 hours, to the 

7 extent possible; and 

8 ‘‘(F) ensures that the prescription drug 

9 monitoring program of the State notifies pre10 scribers and dispensers of schedule II, III, or 

11 IV controlled substances when overuse or mis12 use of such controlled substances by patients is 

13 suspected. 

14 ‘‘(c) AUTHORIZATION OF APPROPRIATIONS.—There 

15 are authorized to be appropriated to carry out this section 

16 $15,000,000 for each of fiscal years 2016 through 2020.’’. 

17 TITLE VII—OFFSET; GAO 

18 REPORT 

19 SEC. 701. OFFSET. 

20 It is the sense of Congress that the amounts ex21 pended to carry out this Act and the amendments made 

22 by this Act should be offset by a corresponding reduction 

23 in Federal non-defense discretionary spending. 


emcdonald on DSK67QTVN1PROD with BILLS
84 

•HR 953 IH

1 SEC. 702. GAO REPORT ON IMD EXCLUSION. 

2 (a) DEFINITION.—In this section, the term ‘‘Med3 icaid Institutions for Mental Disease exclusion’’ means the 

4 prohibition on Federal matching payments under Medicaid 

5 for patients who have attained age 22, but have not at6 tained age 65, in an institution for mental diseases under 

7 subparagraph (B) of the matter following subsection (a) 

8 of section 1905 of the Social Security Act and subsection 

9 (i) of such section (42 U.S.C. 1396d). 

10 (b) REPORT REQUIRED.—Not later than 180 days 

11 after the date of enactment of this Act, the Comptroller 

12 General of the United States shall submit to Congress a 

13 report on the impact that the Medicaid Institutions for 

14 Mental Disease exclusion has on access to treatment for 

15 individuals with a substance use disorder. 

16 (c) ELEMENTS.—The report required under sub17 section (b) shall include the following: 

18 (1) An analysis of whether the following policy 

19 changes to the Medicaid Institutions for Mental Dis20 ease exclusion would enhance access to treatment for 

21 individuals with a substance use disorder: 

22 (A) Removing substance use disorder 

23 treatment and facilities from the Medicaid In24 stitutions for Mental Disease exclusion. 

25 (B) Amending section 1905(i) of the Social 

26 Security Act (42 U.S.C. 1396d(i)) to modestly 


emcdonald on DSK67QTVN1PROD with BILLS
85 

•HR 953 IH

1 raise the 16-bed limit in the definition of an in2 stitution for mental diseases under that section. 

3 (C) Repealing the Medicaid Institutions for 

4 Mental Disease exclusion. 

5 (2) An analysis of whether and to what extent 

6 the quality of care for substance use disorder treat7 ment is impacted by the Medicaid Institutions for 

8 Mental Disease exclusion. 

9 (3) An analysis of barriers in accessing State10 specific information related to the impact of the 

11 Medicaid Institutions for Mental Disease exclusion 

12 on access to treatment. 

13 (4) An analysis of the difference in cost be14 tween treatment for a substance use disorder in a 

15 hospital setting compared to a community-based 

16 care setting. 

17 (5) An analysis of the characteristics of institu18 tions for mental diseases (as defined in section 

19 1905(i) of the Social Security Act (42 U.S.C. 

20 1396d(i))), including the patient capacity of such in21 stitutions as well as the type of care setting, among 

22 other characteristics. 

Æ 


emcdonald on DSK67QTVN1PROD with BILLS